<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC5050068/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050068/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Clinical cancer research : an official journal of the American Association for Cancer Research"><meta name="citation_title" content="Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy"><meta name="citation_authors" content="Daniel L. Hertz, Kouros Owzar, Sherrie Lessans, Claudia Wing, Chen Jiang, William Kevin Kelly, Jai Patel, Susan Halabi, Yoichi Furukawa, Heather E. Wheeler, Alexander B. Sibley, Cameron Lassiter, Lois Weisman, Dorothy Watson, Stefanie D. Krens, Flora Mulkey, Cynthia L. Renn, Eric J. Small, Phillip G. Febbo, Ivo Shterev, Deanna L. Kroetz, Paula N. Friedman, John F. Mahoney, Michael A. Carducci, Michael J Kelley, Yusuke Nakamura, Michiaki Kubo, Susan G. Dorsey, M. Eileen Dolan, Michael J. Morris, Mark J. Ratain, Howard L. McLeod"><meta name="citation_date" content="1 October 2016"><meta name="citation_issue" content="19"><meta name="citation_volume" content="22"><meta name="citation_firstpage" content="4890"><meta name="citation_doi" content="10.1158/1078-0432.CCR-15-2823"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC5050068/?report=abstract"><meta name="citation_pmid" content="27143689"><meta name="DC.Title" content="Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Daniel L. Hertz"><meta name="DC.Contributor" content="Kouros Owzar"><meta name="DC.Contributor" content="Sherrie Lessans"><meta name="DC.Contributor" content="Claudia Wing"><meta name="DC.Contributor" content="Chen Jiang"><meta name="DC.Contributor" content="William Kevin Kelly"><meta name="DC.Contributor" content="Jai Patel"><meta name="DC.Contributor" content="Susan Halabi"><meta name="DC.Contributor" content="Yoichi Furukawa"><meta name="DC.Contributor" content="Heather E. Wheeler"><meta name="DC.Contributor" content="Alexander B. Sibley"><meta name="DC.Contributor" content="Cameron Lassiter"><meta name="DC.Contributor" content="Lois Weisman"><meta name="DC.Contributor" content="Dorothy Watson"><meta name="DC.Contributor" content="Stefanie D. Krens"><meta name="DC.Contributor" content="Flora Mulkey"><meta name="DC.Contributor" content="Cynthia L. Renn"><meta name="DC.Contributor" content="Eric J. Small"><meta name="DC.Contributor" content="Phillip G. Febbo"><meta name="DC.Contributor" content="Ivo Shterev"><meta name="DC.Contributor" content="Deanna L. Kroetz"><meta name="DC.Contributor" content="Paula N. Friedman"><meta name="DC.Contributor" content="John F. Mahoney"><meta name="DC.Contributor" content="Michael A. Carducci"><meta name="DC.Contributor" content="Michael J Kelley"><meta name="DC.Contributor" content="Yusuke Nakamura"><meta name="DC.Contributor" content="Michiaki Kubo"><meta name="DC.Contributor" content="Susan G. Dorsey"><meta name="DC.Contributor" content="M. Eileen Dolan"><meta name="DC.Contributor" content="Michael J. Morris"><meta name="DC.Contributor" content="Mark J. Ratain"><meta name="DC.Contributor" content="Howard L. McLeod"><meta name="DC.Date" content="2016 Oct 1"><meta name="DC.Identifier" content="10.1158/1078-0432.CCR-15-2823"><meta name="DC.Language" content="en"><meta property="og:title" content="Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy"><meta property="og:type" content="article"><meta property="og:description" content="Discovery of single nucleotide polymorphisms (SNPs) that predict a patient's risk of docetaxel-induced neuropathy would enable treatment individualization to maximize efficacy and avoid unnecessary toxicity. The objectives of this analysis were to discover ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050068/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC5050068/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC5050068/pdf/nihms782777.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE8D21E5DD58B3710000000007750476.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5050068%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC5050068</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Clin Cancer Res</a></span>. Author manuscript; available in PMC 2017 Oct 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=27143689" target="pmc_ext" ref="reftype=publisher&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access"><span class="cit">Clin Cancer Res. 2016 Oct 1; 22(19): 4890–4900. </span></a></div><span class="fm-vol-iss-date">Published online 2016 May 3. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1158%2F1078-0432.CCR-15-2823" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1158/1078-0432.CCR-15-2823</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC5050068</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS782777</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/27143689">27143689</a></div></div></div></div><h1 class="content-title">Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a <em>VAC14</em> Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Hertz%20DL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129547661984" co-class="co-affbox">Daniel L. Hertz</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Owzar%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129547647696" co-class="co-affbox">Kouros Owzar</a>,<sup>3,</sup><sup>4</sup> <a href="/pubmed/?term=Lessans%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129547645536" co-class="co-affbox">Sherrie Lessans</a>,<sup>5</sup> <a href="/pubmed/?term=Wing%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129477604608" co-class="co-affbox">Claudia Wing</a>,<sup>6</sup> <a href="/pubmed/?term=Jiang%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129477602624" co-class="co-affbox">Chen Jiang</a>,<sup>4</sup> <a href="/pubmed/?term=Kelly%20WK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129477600640" co-class="co-affbox">William Kevin Kelly</a>,<sup>7</sup> <a href="/pubmed/?term=Patel%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129477598656" co-class="co-affbox">Jai Patel</a>,<sup>2,</sup><sup>8</sup> <a href="/pubmed/?term=Halabi%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129477595936" co-class="co-affbox">Susan Halabi</a>,<sup>3,</sup><sup>4</sup> <a href="/pubmed/?term=Furukawa%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129477593216" co-class="co-affbox">Yoichi Furukawa</a>,<sup>9</sup> <a href="/pubmed/?term=Wheeler%20HE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129477591232" co-class="co-affbox">Heather E. Wheeler</a>,<sup>6</sup> <a href="/pubmed/?term=Sibley%20AB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129477589248" co-class="co-affbox">Alexander B. Sibley</a>,<sup>3</sup> <a href="/pubmed/?term=Lassiter%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129477587264" co-class="co-affbox">Cameron Lassiter</a>,<sup>5</sup> <a href="/pubmed/?term=Weisman%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129478482256" co-class="co-affbox">Lois Weisman</a>,<sup>10</sup> <a href="/pubmed/?term=Watson%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129478480272" co-class="co-affbox">Dorothy Watson</a>,<sup>4</sup> <a href="/pubmed/?term=Krens%20SD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129478478288" co-class="co-affbox">Stefanie D. Krens</a>,<sup>2,</sup><sup>11</sup> <a href="/pubmed/?term=Mulkey%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129478475568" co-class="co-affbox">Flora Mulkey</a>,<sup>4</sup> <a href="/pubmed/?term=Renn%20CL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129478473584" co-class="co-affbox">Cynthia L. Renn</a>,<sup>5</sup> <a href="/pubmed/?term=Small%20EJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129478471600" co-class="co-affbox">Eric J. Small</a>,<sup>12</sup> <a href="/pubmed/?term=Febbo%20PG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129478469616" co-class="co-affbox">Phillip G. Febbo</a>,<sup>13</sup> <a href="/pubmed/?term=Shterev%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129478467632" co-class="co-affbox">Ivo Shterev</a>,<sup>14</sup> <a href="/pubmed/?term=Kroetz%20DL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129478465648" co-class="co-affbox">Deanna L. Kroetz</a>,<sup>15</sup> <a href="/pubmed/?term=Friedman%20PN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129478463664" co-class="co-affbox">Paula N. Friedman</a>,<sup>6</sup> <a href="/pubmed/?term=Mahoney%20JF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129476094976" co-class="co-affbox">John F. Mahoney</a>,<sup>8</sup> <a href="/pubmed/?term=Carducci%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129476092992" co-class="co-affbox">Michael A. Carducci</a>,<sup>16</sup> <a href="/pubmed/?term=Kelley%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129476091008" co-class="co-affbox">Michael J Kelley</a>,<sup>17</sup> <a href="/pubmed/?term=Nakamura%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129476089024" co-class="co-affbox">Yusuke Nakamura</a>,<sup>6,</sup><sup>9</sup> <a href="/pubmed/?term=Kubo%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129476086304" co-class="co-affbox">Michiaki Kubo</a>,<sup>18</sup> <a href="/pubmed/?term=Dorsey%20SG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129476084320" co-class="co-affbox">Susan G. Dorsey</a>,<sup>5</sup> <a href="/pubmed/?term=Dolan%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129476082336" co-class="co-affbox">M. Eileen Dolan</a>,<sup>6</sup> <a href="/pubmed/?term=Morris%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129476080352" co-class="co-affbox">Michael J. Morris</a>,<sup>19</sup> <a href="/pubmed/?term=Ratain%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129476078368" co-class="co-affbox">Mark J. Ratain</a>,<sup>6</sup> and  <a href="/pubmed/?term=McLeod%20HL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689" class="affpopup" co-rid="_co_idm140129476076384" co-class="co-affbox">Howard L. McLeod</a><sup>2,</sup><sup>20</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140129547661984"><h3 class="no_margin">Daniel L. Hertz</h3><p><sup>1</sup>Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA</p><p><sup>2</sup>UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Hertz%20DL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Daniel L. Hertz</a></div></div><div id="_co_idm140129547647696"><h3 class="no_margin">Kouros Owzar</h3><p><sup>3</sup>Duke Cancer Institute, Durham, NC, USA</p><p><sup>4</sup>Alliance Statistics and Data Center, Duke University, Durham, NC, USA; supported by CA33601</p><div>Find articles by <a href="/pubmed/?term=Owzar%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Kouros Owzar</a></div></div><div id="_co_idm140129547645536"><h3 class="no_margin">Sherrie Lessans</h3><p><sup>5</sup>Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, USA; supported by CA31983</p><div>Find articles by <a href="/pubmed/?term=Lessans%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Sherrie Lessans</a></div></div><div id="_co_idm140129477604608"><h3 class="no_margin">Claudia Wing</h3><p><sup>6</sup>Department of Medicine, University of Chicago, Chicago, IL, USA; supported by CA41287</p><div>Find articles by <a href="/pubmed/?term=Wing%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Claudia Wing</a></div></div><div id="_co_idm140129477602624"><h3 class="no_margin">Chen Jiang</h3><p><sup>4</sup>Alliance Statistics and Data Center, Duke University, Durham, NC, USA; supported by CA33601</p><div>Find articles by <a href="/pubmed/?term=Jiang%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Chen Jiang</a></div></div><div id="_co_idm140129477600640"><h3 class="no_margin">William Kevin Kelly</h3><p><sup>7</sup>Thomas Jefferson University, Philadelphia, PA, USA</p><div>Find articles by <a href="/pubmed/?term=Kelly%20WK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">William Kevin Kelly</a></div></div><div id="_co_idm140129477598656"><h3 class="no_margin">Jai Patel</h3><p><sup>2</sup>UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA</p><p><sup>8</sup>Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Patel%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Jai Patel</a></div></div><div id="_co_idm140129477595936"><h3 class="no_margin">Susan Halabi</h3><p><sup>3</sup>Duke Cancer Institute, Durham, NC, USA</p><p><sup>4</sup>Alliance Statistics and Data Center, Duke University, Durham, NC, USA; supported by CA33601</p><div>Find articles by <a href="/pubmed/?term=Halabi%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Susan Halabi</a></div></div><div id="_co_idm140129477593216"><h3 class="no_margin">Yoichi Furukawa</h3><p><sup>9</sup>Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan</p><div>Find articles by <a href="/pubmed/?term=Furukawa%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Yoichi Furukawa</a></div></div><div id="_co_idm140129477591232"><h3 class="no_margin">Heather E. Wheeler</h3><p><sup>6</sup>Department of Medicine, University of Chicago, Chicago, IL, USA; supported by CA41287</p><div>Find articles by <a href="/pubmed/?term=Wheeler%20HE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Heather E. Wheeler</a></div></div><div id="_co_idm140129477589248"><h3 class="no_margin">Alexander B. Sibley</h3><p><sup>3</sup>Duke Cancer Institute, Durham, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Sibley%20AB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Alexander B. Sibley</a></div></div><div id="_co_idm140129477587264"><h3 class="no_margin">Cameron Lassiter</h3><p><sup>5</sup>Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, USA; supported by CA31983</p><div>Find articles by <a href="/pubmed/?term=Lassiter%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Cameron Lassiter</a></div></div><div id="_co_idm140129478482256"><h3 class="no_margin">Lois Weisman</h3><p><sup>10</sup>Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA</p><div>Find articles by <a href="/pubmed/?term=Weisman%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Lois Weisman</a></div></div><div id="_co_idm140129478480272"><h3 class="no_margin">Dorothy Watson</h3><p><sup>4</sup>Alliance Statistics and Data Center, Duke University, Durham, NC, USA; supported by CA33601</p><div>Find articles by <a href="/pubmed/?term=Watson%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Dorothy Watson</a></div></div><div id="_co_idm140129478478288"><h3 class="no_margin">Stefanie D. Krens</h3><p><sup>2</sup>UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA</p><p><sup>11</sup>Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht, The Netherlands</p><div>Find articles by <a href="/pubmed/?term=Krens%20SD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Stefanie D. Krens</a></div></div><div id="_co_idm140129478475568"><h3 class="no_margin">Flora Mulkey</h3><p><sup>4</sup>Alliance Statistics and Data Center, Duke University, Durham, NC, USA; supported by CA33601</p><div>Find articles by <a href="/pubmed/?term=Mulkey%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Flora Mulkey</a></div></div><div id="_co_idm140129478473584"><h3 class="no_margin">Cynthia L. Renn</h3><p><sup>5</sup>Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, USA; supported by CA31983</p><div>Find articles by <a href="/pubmed/?term=Renn%20CL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Cynthia L. Renn</a></div></div><div id="_co_idm140129478471600"><h3 class="no_margin">Eric J. Small</h3><p><sup>12</sup>Department of Medicine, UCSF, San Francisco, CA, USA; supported by CA60138</p><div>Find articles by <a href="/pubmed/?term=Small%20EJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Eric J. Small</a></div></div><div id="_co_idm140129478469616"><h3 class="no_margin">Phillip G. Febbo</h3><p><sup>13</sup>Genomic Health, Redwood City, CA, USA</p><div>Find articles by <a href="/pubmed/?term=Febbo%20PG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Phillip G. Febbo</a></div></div><div id="_co_idm140129478467632"><h3 class="no_margin">Ivo Shterev</h3><p><sup>14</sup>Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Shterev%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Ivo Shterev</a></div></div><div id="_co_idm140129478465648"><h3 class="no_margin">Deanna L. Kroetz</h3><p><sup>15</sup>Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA</p><div>Find articles by <a href="/pubmed/?term=Kroetz%20DL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Deanna L. Kroetz</a></div></div><div id="_co_idm140129478463664"><h3 class="no_margin">Paula N. Friedman</h3><p><sup>6</sup>Department of Medicine, University of Chicago, Chicago, IL, USA; supported by CA41287</p><div>Find articles by <a href="/pubmed/?term=Friedman%20PN%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Paula N. Friedman</a></div></div><div id="_co_idm140129476094976"><h3 class="no_margin">John F. Mahoney</h3><p><sup>8</sup>Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA</p><div>Find articles by <a href="/pubmed/?term=Mahoney%20JF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">John F. Mahoney</a></div></div><div id="_co_idm140129476092992"><h3 class="no_margin">Michael A. Carducci</h3><p><sup>16</sup>The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA</p><div>Find articles by <a href="/pubmed/?term=Carducci%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Michael A. Carducci</a></div></div><div id="_co_idm140129476091008"><h3 class="no_margin">Michael J Kelley</h3><p><sup>17</sup>Durham VA Medical Center, Duke University Medical Center, Durham, NC, USA; supported by CA47577</p><div>Find articles by <a href="/pubmed/?term=Kelley%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Michael J Kelley</a></div></div><div id="_co_idm140129476089024"><h3 class="no_margin">Yusuke Nakamura</h3><p><sup>6</sup>Department of Medicine, University of Chicago, Chicago, IL, USA; supported by CA41287</p><p><sup>9</sup>Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan</p><div>Find articles by <a href="/pubmed/?term=Nakamura%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Yusuke Nakamura</a></div></div><div id="_co_idm140129476086304"><h3 class="no_margin">Michiaki Kubo</h3><p><sup>18</sup>Lab for Genotyping Development, Riken Center for Integrative Medical Sciences, Kanagawa, Japan</p><div>Find articles by <a href="/pubmed/?term=Kubo%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Michiaki Kubo</a></div></div><div id="_co_idm140129476084320"><h3 class="no_margin">Susan G. Dorsey</h3><p><sup>5</sup>Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, USA; supported by CA31983</p><div>Find articles by <a href="/pubmed/?term=Dorsey%20SG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Susan G. Dorsey</a></div></div><div id="_co_idm140129476082336"><h3 class="no_margin">M. Eileen Dolan</h3><p><sup>6</sup>Department of Medicine, University of Chicago, Chicago, IL, USA; supported by CA41287</p><div>Find articles by <a href="/pubmed/?term=Dolan%20ME%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">M. Eileen Dolan</a></div></div><div id="_co_idm140129476080352"><h3 class="no_margin">Michael J. Morris</h3><p><sup>19</sup>Memorial Sloan Kettering Cancer Center, New York, NY, USA; supported by CA47577</p><div>Find articles by <a href="/pubmed/?term=Morris%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Michael J. Morris</a></div></div><div id="_co_idm140129476078368"><h3 class="no_margin">Mark J. Ratain</h3><p><sup>6</sup>Department of Medicine, University of Chicago, Chicago, IL, USA; supported by CA41287</p><div>Find articles by <a href="/pubmed/?term=Ratain%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Mark J. Ratain</a></div></div><div id="_co_idm140129476076384"><h3 class="no_margin">Howard L. McLeod</h3><p><sup>2</sup>UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA</p><p><sup>20</sup>Personalized Medicine Institute, Moffitt Cancer Center, Tampa, FL, USA</p><div>Find articles by <a href="/pubmed/?term=McLeod%20HL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27143689">Howard L. McLeod</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140129477684880_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140129477684880_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140129477684880_ai" style="display:none"><div class="fm-affl" id="A1" lang="en"><sup>1</sup>Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA</div><div class="fm-affl" id="A2" lang="en"><sup>2</sup>UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA</div><div class="fm-affl" id="A3" lang="en"><sup>3</sup>Duke Cancer Institute, Durham, NC, USA</div><div class="fm-affl" id="A4" lang="en"><sup>4</sup>Alliance Statistics and Data Center, Duke University, Durham, NC, USA; supported by CA33601</div><div class="fm-affl" id="A5" lang="en"><sup>5</sup>Department of Pain and Translational Symptom Science, University of Maryland School of Nursing, Baltimore, MD, USA; supported by CA31983</div><div class="fm-affl" id="A6" lang="en"><sup>6</sup>Department of Medicine, University of Chicago, Chicago, IL, USA; supported by CA41287</div><div class="fm-affl" id="A7" lang="en"><sup>7</sup>Thomas Jefferson University, Philadelphia, PA, USA</div><div class="fm-affl" id="A8" lang="en"><sup>8</sup>Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA</div><div class="fm-affl" id="A9" lang="en"><sup>9</sup>Division of Clinical Genome Research, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan</div><div class="fm-affl" id="A10" lang="en"><sup>10</sup>Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA</div><div class="fm-affl" id="A11" lang="en"><sup>11</sup>Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht, The Netherlands</div><div class="fm-affl" id="A12" lang="en"><sup>12</sup>Department of Medicine, UCSF, San Francisco, CA, USA; supported by CA60138</div><div class="fm-affl" id="A13" lang="en"><sup>13</sup>Genomic Health, Redwood City, CA, USA</div><div class="fm-affl" id="A14" lang="en"><sup>14</sup>Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA</div><div class="fm-affl" id="A15" lang="en"><sup>15</sup>Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA</div><div class="fm-affl" id="A16" lang="en"><sup>16</sup>The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA</div><div class="fm-affl" id="A17" lang="en"><sup>17</sup>Durham VA Medical Center, Duke University Medical Center, Durham, NC, USA; supported by CA47577</div><div class="fm-affl" id="A18" lang="en"><sup>18</sup>Lab for Genotyping Development, Riken Center for Integrative Medical Sciences, Kanagawa, Japan</div><div class="fm-affl" id="A19" lang="en"><sup>19</sup>Memorial Sloan Kettering Cancer Center, New York, NY, USA; supported by CA47577</div><div class="fm-affl" id="A20" lang="en"><sup>20</sup>Personalized Medicine Institute, Moffitt Cancer Center, Tampa, FL, USA</div><div id="FN1">Address reprint requests to Dr. McLeod at Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612. Phone: (813) 745-8435. Fax: (813) 745-6525. <a href="mailto:dev@null" data-email="gro.ttiffom@doelcm.drawoH" class="oemail">gro.ttiffom@doelcm.drawoH</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140129477684880_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available free at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=27143689" target="pmc_ext" ref="reftype=publisher&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CFree%20Access">Clin Cancer Res</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC5050068/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="6" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>1.</strong></div><div><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-1.png" data-ga-action="click_feat_suppl">NIHMS782777-supplement-1.png</a><span style="color:gray"> (112K)</span></div><div class="small guid">GUID:&nbsp;B51C656C-87A9-41E0-99A0-2277E91E7745</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>2.</strong></div><div><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-2.jpg" data-ga-action="click_feat_suppl">NIHMS782777-supplement-2.jpg</a><span style="color:gray"> (44K)</span></div><div class="small guid">GUID:&nbsp;2AA56660-0736-4F90-8DC0-12A44BA5E586</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>3.</strong></div><div><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-3.png" data-ga-action="click_feat_suppl">NIHMS782777-supplement-3.png</a><span style="color:gray"> (19K)</span></div><div class="small guid">GUID:&nbsp;8216DF65-7C53-460C-9521-508A6596DFEA</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>4.</strong></div><div><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-4.doc" data-ga-action="click_feat_suppl">NIHMS782777-supplement-4.doc</a><span style="color:gray"> (49K)</span></div><div class="small guid">GUID:&nbsp;4C3A9BF0-7EF5-480C-A382-2D271674235E</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>5.</strong></div><div><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-5.doc" data-ga-action="click_feat_suppl">NIHMS782777-supplement-5.doc</a><span style="color:gray"> (1.1M)</span></div><div class="small guid">GUID:&nbsp;3C4D3D41-C96B-4A2D-BCDA-7C7E417F933F</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>6.</strong></div><div><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-6.docx" data-ga-action="click_feat_suppl">NIHMS782777-supplement-6.docx</a><span style="color:gray"> (14K)</span></div><div class="small guid">GUID:&nbsp;2FA2007C-5292-4A1F-99CA-B85EE0589AD9</div></div></dd></dl></div><div id="idm140129478701008" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140129478701008title">Abstract</h2><!--article-meta--><div><div id="S1" class="sec sec-first"><h3 id="S1title">Purpose</h3><p id="P1" class="p p-first-last">Discovery of single nucleotide polymorphisms (SNPs) that predict a patient's risk of docetaxel-induced neuropathy would enable treatment individualization to maximize efficacy and avoid unnecessary toxicity. The objectives of this analysis were to discover SNPs associated with docetaxel-induced neuropathy and mechanistically validate these associations in preclinical models of drug-induced neuropathy.</p></div><div id="S2" class="sec"><h3 id="S2title">Experimental Design</h3><p id="P2" class="p p-first-last">A genome-wide association study was conducted in metastatic castrate-resistant prostate cancer patients treated with docetaxel, prednisone and randomized to bevacizumab or placebo on CALGB 90401. SNPs were genotyped on the Illumina HumanHap610-Quad platform followed by rigorous quality control. The inference was conducted on the cumulative dose at occurrence of grade 3+ sensory neuropathy using a cause-specific hazard model that accounted for early treatment discontinuation. Genes with SNPs significantly associated with neuropathy were knocked down in cellular and mouse models of drug-induced neuropathy.</p></div><div id="S3" class="sec"><h3 id="S3title">Results</h3><p id="P3" class="p p-first-last">498,081 SNPs were analyzed in 623 Caucasian patients, 50 (8%) of whom experienced grade 3+ neuropathy. The 1000 SNPs most associated with neuropathy clustered in relevant pathways including neuropathic pain and axonal guidance. A SNP in <em>VAC14</em> (rs875858) surpassed genome-wide significance (p=2.12×10<sup>-8</sup> adjusted p=5.88×10<sup>-7</sup>). siRNA knockdown of VAC14 in stem cell derived peripheral neuronal cells increased docetaxel sensitivity as measured by decreased neurite processes (p=0.0015) and branches (p&lt;0.0001). Prior to docetaxel treatment <em>VAC14</em> heterozygous mice had greater nociceptive sensitivity than wild-type litter mate controls (p=0.001).</p></div><div id="S4" class="sec sec-last"><h3 id="S4title">Conclusions</h3><p id="P4" class="p p-first-last"><em>VAC14</em> should be prioritized for further validation of its potential role as a predictor of docetaxel-induced neuropathy and biomarker for treatment individualization.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">docetaxel, paclitaxel, pharmacogenetics, genome-wide association study, heritability, single nucleotide polymorphism, chemotherapy-induced peripheral neuropathy, VAC14, peripheral neuronal cell model, animal model</span></div></div><div id="S5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S5title">Introduction</h2><p id="P5" class="p p-first">The taxane class includes three US Food and Drug Administration (FDA)-approved chemotherapeutic agents, paclitaxel, docetaxel and cabazitaxel, that have activity in a variety of solid tumors including lung, breast, ovarian, gastric, and prostate cancers. Taxanes bind to and stabilize microtubules, ultimately inhibiting the mitotic phase of cell cycle development(<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886876">1</a>). The taxanes and other microtubule-targeting chemotherapeutic agents (e.g., vinca alkaloids) commonly induce peripheral neuropathy of varying severity(<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886881">2</a>). Chemotherapy-induced peripheral neuropathy (CIPN) often presents as a combination of paresthesia and dysesthesia, and can progress to irreversible loss of balance and dexterity with continued treatment(<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886886">3</a>). Due to the progressive nature of the toxicity and its potential effect on long-term quality of life(<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886872">4</a>), CIPN can necessitate treatment discontinuation, even in the context of active tumor control.</p><p id="P6">Patient demographic (i.e., race and history of neuropathy) and treatment (i.e., cumulative dose and drug exposure) factors have been associated with CIPN(<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886840">5</a>-<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886831">8</a>), but there are currently no effective methods for predicting CIPN risk and/or severity. Genome-wide association studies (GWAS) of paclitaxel and vincristine-induced CIPN confirm that genetic variation modifies patients' risk(<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886827">9</a>-<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886896">12</a>). The discovery and validation of single nucleotide polymorphisms (SNPs) that influence risk of docetaxel-induced peripheral neuropathy would be of clinical benefit, enabling identification of high-risk patients in whom taxane use should be avoided if possible. SNPs that modulate risk of docetaxel-induced neuropathy have been reported from candidate gene studies(<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886865">13</a>-<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886833">15</a>); however, no study has taken a genome-wide approach. Based on the previous success of GWAS in discovering SNPs that affect paclitaxel-induced neuropathy, a similar analysis was conducted in a cohort of docetaxel-treated patients to identify genetic predictors of docetaxel-induced neuropathy.</p><p id="P7" class="p p-last">GWAS was performed in a large, prospectively enrolled, chemotherapy-naive cohort of metastatic castrate-resistant prostate cancer (mCRPC) patients who were treated with up to two years of docetaxel and prednisone, with half randomized to concurrent bevacizumab(<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886890">16</a>). As these metastatic patients are at high risk of early treatment discontinuation due to disease progression and/or death, which precludes occurrence of neuropathy, a competing-risks adjusted statistical model was utilized(<a href="#R17" rid="R17" class=" bibr popnode">17</a>, <a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886843">18</a>). Following discovery of a SNP that surpassed genome-wide significance, pharmacogenetic replication between the results of a previously conducted GWAS of paclitaxel-induced neuropathy(<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886862">9</a>) and this GWAS of docetaxel-induced neuropathy and mechanistic validation of that gene in cellular and animal models were attempted to determine whether genetic predictors of CIPN were similar between the taxanes and to potentially validate clinically useful genetic predictors of docetaxel-induced sensory peripheral neuropathy</p></div><div id="S6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S6title">Methods</h2><div id="S7" class="sec sec-first"><h3 id="S7title">Patients and toxicity</h3><p id="P8" class="p p-first-last">Cancer and Leukeumia Group B (CALGB/Alliance) 90401 was a double-blinded phase III trial that equally randomized men with hormone-refractory prostate cancer to receive docetaxel and prednisone with or without bevacizumab for up to two years(<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886830">16</a>). All patients enrolled in the CALGB 90401 parent study who provided IRB-approved informed consent for a pharmacogenomic substudy (CALGB 60404) were eligible for this GWAS. Briefly, patient eligibility included histologically documented adenocarcinoma of the prostate that had progressed while the patient was on hormone deprivation therapy. Relevant exclusion criteria included prior chemotherapy or anti-angiogenesis therapy or clinically significant (grade 2+) peripheral neuropathy. Toxicity data were collected by the Alliance Statistics and Data Center at each treatment cycle on standardized forms that mandated reporting of grade 3+ peripheral sensory neuropathy, as defined by National Cancer Institute Common Toxicity Criteria for Adverse Events (NCI CTCAE) version 3.0. Additionally, one case was reported as a grade 3 cranial neuropathy event described as “sensory-facial.” Only neuropathy that was considered by the clinician to be possibly, probably, or definitely attributable to treatment, and occurred within 30 days of docetaxel administration, was included in the analysis.</p></div><div id="S8" class="sec"><h3 id="S8title">Docetaxel treatment</h3><p id="P9" class="p p-first-last">All patients received docetaxel 75 mg/m<sup>2</sup> infused over 1 hour on day 1 of each 21-day cycle with 8 mg oral dexamethasone 12, 3, and 1 hour prior to infusion. Patients on both arms also received 5 mg oral prednisone twice daily and were randomized to 15 mg/kg bevacizumab or placebo by intravenous infusion on day 1 of each cycle. Use of growth factor, aspirin, anti-emetics and luteinizing-hormone releasing hormone agonists was under the discretion of the treating physician. Docetaxel administration was held for neutropenia (absolute neutrophil count &lt;1,500 cells/mm<sup>3</sup>) and the dose was decreased in increments of 10 mg/m<sup>2</sup> for hepatic dysfunction, neurotoxicity, gastrointestinal toxicity or febrile neutropenia. The protocol mandated discontinuation of docetaxel treatment if the patient required more than two docetaxel dose decreases or in the event of specific toxicities or confirmed cancer progression.</p></div><div id="S9" class="sec"><h3 id="S9title">Genotyping</h3><p id="P10" class="p p-first-last">A 10-mL sample of whole blood was collected from all patients enrolling on the pharmacogenomic substudy prior to initiation of protocol treatment. Genotyping and genetic quality control were similar to that previously reported in the CALGB 40101 GWAS(<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886847">9</a>). Genotyping was performed on the HumanHap610-Quad Genotyping BeadChip (Illumina Inc., CA, USA) at the RIKEN Center for Genomic Medicine (Yokohama City, Japan). Genotype data is available at dbGap (<a href="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001002.v1.p1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001002.v1.p1</a>) SNPs that were known indeterminate (n=4,106) or unreliable loci (Tech Note: Infinium® Genotyping Data Analysis, 2007) and patients with SNP call rate &lt;95% were excluded. Eigensoft version 3.0 was used to visualize genetic ancestry for the 790 evaluable patients to identify a genetic European population (n=623) in which the analysis was conducted. Additional SNPs were excluded for low call rate (&lt;99%), low minor allele frequency (&lt;0.05), p-value of Hardy-Weinberg distribution &lt;10<sup>-8</sup> or non-autosomal loci, leaving 498,081 SNPs for analysis (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 1</a>).</p></div><div id="S10" class="sec"><h3 id="S10title">Cellular Sensitivity Experiments</h3><p id="P11" class="p p-first-last">Commercially available human induced pluripotent stem cell (iPSC)-derived peripheral neurons (Peri.4U) were purchased from Axiogenesis (Cologne, Germany) and plated at 1 × 10<sup>4</sup> cells/well in 100 μL media as per manufactures' instructions. <a href="/pmc/articles/PMC5050068/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3A</span></a> illustrates the scheme for this experiment. Dharmacon Accell technology (GE Dharmacon, Lafayette, CO, USA) was applied at 4 hours post-plating using 1 μM human si<em>VAC14</em> SMARTpool or the non-targeting control (NTC). 24 hours later, transfection media was exchanged for media containing 0.17% DMSO vehicle control and either docetaxel (LKT Laboratories Inc., St. Paul, MN) or paclitaxel (Sigma-Aldrich, St. Louis, MO). The drugs were prepared in a darkened hood by dissolving powder in 100% DMSO to obtain a stock solution of 58.4 mM. Stock drug was serially diluted in media for final dosing concentrations ranging from 10 pM to 1 μM, increasing by factors of ten. Control wells were treated with 0.17% final concentration of DMSO to match drug treatments. After 24 or 48 hour drug treatments, neurons were stained with 0.3 ng/mL Hoechst 33342 (Sigma-Aldrich) and 1.5 μg/mL Calcein AM (Molecular Probes, Life Technologies Inc.) and imaged at 10× magnification using an ImageXpress Micro imaging microscope (Molecular Devices, LLC, Sunnyvale, CA) at the University of Chicago Cellular Screening Center. Neurite changes were determined by individual cell measurements of relative total neurite outgrowth, relative number of processes, relative number of branches, mean/median/max process length, relative cell body area, relative straightness and relative mean outgrowth intensity. The data represents triplicate experiments making measurements on more than 1000 cells per treatment as previously described(<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886889">19</a>). Two wells of transfected cells were collected per timepoint using the Cells-to-Ct kit (Ambion, Life Technologies Inc., Carlsbad, CA) and reversed transcribed as per kit instructions. Quantitative real time reverse transcription polymerase chain reaction (qRT-PCR) was performed using Taqman primers (Fisher Scientific LLC, Hanover Park, IL) for <em>VAC14</em> (Hs00947931_m1) and compared to human beta-2-microglobulin (<a id="__tag_561886938" class="tag_hotlink" href="/nuccore/NM_004048.2" ref="/nuccore/NM_004048.2"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"NM_004048.2","term_id":"37704380","term_text":"NM_004048.2"}}</span>NM_004048.2</a>) housekeeping gene at 24, 48 and 72 hours post-transfection (as previously described; (<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886828">19</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC5050068/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140129479262480" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms782777f3.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms782777f3.jpg" src="/pmc/articles/PMC5050068/bin/nihms782777f3.jpg"></div></a><div id="largeobj_idm140129479262480" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC5050068/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a target="object" href="/pmc/articles/PMC5050068/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC5050068/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong><em>VAC14</em> Knockdown increases neuronal cell sensitivity to docetaxel but decreases sensitivity to paclitaxel</strong><p id="__p7">A) Peripheral neuron (Peri.4U) experimental scheme illustrating timing of treatment and imaging. B) Relative VAC14 expression at 24, 48 and 72 hours post-transfection with siVAC14 compared to non-targeting control (NTC) produced a steady decline of VAC14 expression over time. The neurite outgrowth changes after 24 hours docetaxel (48 hours knockdown) showed no significance as measured by C) total outgrowth but did result in greater sensitivity to docetaxel in D) relative number of processes and E) relative number of branches. Alternatively, VAC14 knockdown decreased peripheral neuronal cell sensitivity to paclitaxel, 3F-3H. Open circle represent data from VAC14 siRNA and closed circle from NTC siRNA. Neurite parameters measured with MetaXPress® software were averaged from 3 independent experiments. Error bars represent the standard error of the mean from three independent transfection experiments. NTC = non-targeting control, UT= untransfected control.</p></div></div></div></div><div id="S11" class="sec"><h3 id="S11title">Mouse Sensitivity Experiments</h3><p id="P12" class="p p-first">Mice bred for <em>VAC14</em> heterozygosity (VAC14<sup>+/-</sup>) and <em>VAC14</em> wild-type litter mates (VAC14<sup>+/+</sup>) on C57/BL6 background were obtained from Lois Weisman at University of Michigan and acclimated to living conditions at University of Maryland(<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886875">20</a>). Mice 3-5 months of age were randomly assigned to docetaxel or placebo treatment, with 6-7 mice in each treatment arm. The entire experiment was conducted separately in male and female mice. Intraperitoneal administration of docetaxel 2 mg/kg or saline vehicle was administered on days 1, 3, 5, and 7.</p><p id="P13" class="p p-last">Behavioral testing for the development of increased mechanical sensitivity took place at baseline (prior to treatment), day 5 (after two doses), day 8 (24 hours after the fourth dose), and weekly for 3 additional assessments. Mechanical sensitivity was measured in mice from both treatment arms simultaneously by a blinded individual using von Frey filaments, as previously described(<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886842">21</a>). Briefly, mice were placed in individual Plexiglas® cubes on an elevated wire mesh platform and allowed to acclimate for approximately one hour, when grooming and exploration behaviors ended. A series of von Frey filaments (Touch Test Sensory Evaluator Kit, <a href="http://myNeurolab.com" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">myNeurolab.com</a>, St. Louis, MO), with bending forces of 0.04-2.0 g, were applied to the plantar surface of the left hind paw until the filament just bent and was held in place for 5 seconds or until the mouse withdrew its paw. A positive response was defined as a brisk withdrawal, with or without shaking or licking, of the hind paw during or immediately upon removal of the filament application. Each filament was tested 5 times on each hind paw starting with the 0.4 g filament. If the 0.4 g filament elicited 3 positive responses out of 5 trials, then testing continued moving downward through the series to the 0.04 g filament and the number of withdrawals was recorded for each filament. If the 0.4 g filament did not elicit 3 positive responses, then testing continued moving upward through the series to the 2.0 g filament and the number of withdrawals was recorded for each filament. Threshold was defined as the filament with the lowest bending force that elicited at least 3 positive responses out of 5 trials.</p></div><div id="S12" class="sec sec-last"><h3 id="S12title">Statistics</h3><p id="P14" class="p p-first">The primary endpoint for GWAS analysis was the cumulative docetaxel dose (mg/m<sup>2</sup>) at first report of treatment-related grade 3+ sensory peripheral neuropathy. Patients who did not complete two years of therapy due to progression/death, treatment-terminating adverse event, or any other reason were informatively censored at the cumulative docetaxel dose received; therefore, the statistical analysis was conducted within a competing-risk model framework with the inference conducted on the basis of cause-specific hazard(<a href="#R17" rid="R17" class=" bibr popnode">17</a>, <a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886864">18</a>). Cumulative incidence curves were constructed to visualize the influence of each of the top three hits with neuropathy incidence. The relationship between each SNP and neuropathy was adjusted for clinical covariates with putative relevance to neuropathy risk: diabetes (reported history of diabetes or current diabetes treatment vs. none), age (continuous), body mass index (BMI) (≤ 30 kg/m<sup>2</sup> vs. &gt; 30 kg/m<sup>2</sup>), and treatment arm (bevacizumab vs. placebo), regardless of whether the covariate was significantly associated with neuropathy in this cohort.</p><p id="P15">Cross-study clinical replication of the SNP with the greatest association with neuropathy was attempted in a cohort of Caucasian breast cancer patients treated with paclitaxel on the CALGB 40101 clinical trial(<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886897">22</a>). GWAS of the cumulative paclitaxel dose at occurrence of grade 2+ neuropathy has previously been published(<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886857">9</a>). Additionally, a SNP predictive of paclitaxel-induced neuropathy risk (rs10771973, <em>FGD4</em>) discovered and replicated in the CALGB 40101 GWAS was interrogated in the GWAS results from the docetaxel-treated Caucasian patients on CALGB 90401 to assess whether the SNPs that influence neuropathy risk are similar between the two taxanes.</p><p id="P16">Statistical analyses were performed by Alliance statisticians on a database locked on August 15, 2012. All analyses were conducted using the R [R]statistical environment version 3.1.1(<a href="#R23" rid="R23" class=" bibr popnode">23</a>) or higher, using extension packages survival (version 2.37-7)(<a href="#R24" rid="R24" class=" bibr popnode">24</a>), GenABEL (version 1.8-0)(<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886863">25</a>), cmprsk (version 2.2-7)(<a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886893">26</a>) and interval (version 1.1-0.1)(<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886885">27</a>). To search for cumulative genetic effects, the genes that mapped to the top 1000 SNPs were included in a pathway enrichment analysis using the Ingenuity Pathway Analysis version 17199142 (Ingenuity® Systems, Inc, <a href="http://www.ingenuity.com" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.ingenuity.com</a>) internal algorithm. Peripheral neuronal cell phenotypes (outgrowth, processes, branching, etc.) measured after treatment with increasing docetaxel and paclitaxel concentrations were compared between <em>VAC14</em> siRNA and non-targeted control siRNA using two-way ANOVA.</p><p id="P17" class="p p-last">Mouse mechanical sensitivity thresholds were compared prior to docetaxel treatment between <em>VAC14</em>+/+ and <em>VAC14</em>+/- mice using an interval-censored analysis with the minimum fiber size inducing a response as the phenotype. The genotype groups in the untreated mice were compared again on day 28. The same method was used to compare sensitivity thresholds of docetaxel treated and untreated mice following treatment on day 8. To assess whether <em>VAC14</em>+/- mice were more sensitive to docetaxel-induced changes in mechanical stimuli, parametric survival regression was used to test for the effect of <em>VAC14</em> by treatment interaction on withdrawal threshold on day 8, after treatment was completed.</p></div></div><div id="S13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S13title">Results</h2><div id="S14" class="sec sec-first"><h3 id="S14title">Genome-wide Association Study</h3><p id="P18" class="p p-first">The CALGB/Alliance 90401 parent study enrolled 1,050 patients, of whom 863 provided consent and registered for the pharmacogenomics substudy CALGB 60604 (CALGB is now a part of the Alliance for Clinical Trials in Oncology). The GWAS included 790 patients, of whom only the 616 self-reported, genetically defined Europeans receiving treatment were included in the analysis to minimize confounding from population substructure (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 1</a>). Demographic characteristics for the discovery cohort including baseline covariates potentially relevant to treatment-induced neuropathy risk are reported in <a href="/pmc/articles/PMC5050068/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>. The median age was 69 years, body mass index (BMI) was 29 kg/m<sup>2</sup>, and 97 patients (16%) had a history of diabetes. Randomization was nearly even to the bevacizumab (314 patients, 51%) and placebo (302, 49%) arms.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p9">Demographic Data for Patients Included in GWAS (n=616).</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140129479255600" class="xtable"><table frame="box" rules="all" class="rendered small default_table"><tbody><tr><td rowspan="2" colspan="1" valign="middle" align="left">Age</td><td rowspan="1" colspan="1" valign="top" align="left">Median (years)</td><td rowspan="1" colspan="1" valign="top" align="left">68.9</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Range (years)</td><td rowspan="1" colspan="1" valign="top" align="left">41.7-93.5</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="left">Body mass index</td><td rowspan="1" colspan="1" valign="top" align="left">Median (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1" valign="top" align="left">29.0</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Range (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1" valign="top" align="left">16.1-53.3</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="left">Diabetes</td><td rowspan="1" colspan="1" valign="top" align="left">Yes</td><td rowspan="1" colspan="1" valign="top" align="left">97 (15.8%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">No</td><td rowspan="1" colspan="1" valign="top" align="left">519 (84.3%)</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="left">Treatment arm</td><td rowspan="1" colspan="1" valign="top" align="left">Bevacizumab</td><td rowspan="1" colspan="1" valign="top" align="left">314 (51.0%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Placebo</td><td rowspan="1" colspan="1" valign="top" align="left">302 (49.0%)</td></tr><tr><td rowspan="2" colspan="1" valign="middle" align="left">Cumulative docetaxel dose</td><td rowspan="1" colspan="1" valign="top" align="left">Median (mg/m<sup>2</sup>)</td><td rowspan="1" colspan="1" valign="top" align="left">626</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Range (mg/m<sup>2</sup>)</td><td rowspan="1" colspan="1" valign="top" align="left">72-2,942</td></tr><tr><td rowspan="3" colspan="1" valign="middle" align="left">ECOG performance status</td><td rowspan="1" colspan="1" valign="top" align="left">0</td><td rowspan="1" colspan="1" valign="top" align="left">340 (55.2%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">1</td><td rowspan="1" colspan="1" valign="top" align="left">258 (41.9%)</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">2</td><td rowspan="1" colspan="1" valign="top" align="left">18 (2.9%)</td></tr><tr><td rowspan="1" colspan="1" valign="middle" align="left">Disease type</td><td rowspan="1" colspan="1" valign="top" align="left">Measurable disease</td><td rowspan="1" colspan="1" valign="top" align="left">310 (50.3%)</td></tr></tbody></table></div><div id="largeobj_idm140129479255600" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5050068/table/T1/?report=objectonly">Open in a separate window</a></div></div><p id="P19">The overall incidence of grade 3+ sensory neuropathy was 8.1% (50/616). The 566 patients who did not experience neuropathy were classified as having either completed treatment without neuropathy (3.9%) or categorized based on their reason for discontinuation: death/progression (41.1%), non-CIPN treatment terminating adverse event (30.2%) or withdrawal/other (16.7%) (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 1</a>). The risk of neuropathy was not significantly different in the bevacizumab and placebo arms (p=0.11), which were pooled for analysis.</p><p id="P20">GWAS analysis was performed on the cumulative docetaxel dose (mg/m<sup>2</sup>) at first report of treatment-induced grade 3+ sensory peripheral neuropathy (<a href="/pmc/articles/PMC5050068/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). The ten most significant SNPs, ranked according to the unadjusted p-value for cause-specific association with neuropathy, are listed in <a href="/pmc/articles/PMC5050068/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a> with rsID, gene annotation, and hazard ratios before and after adjustment (Top 1000 SNPs in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 2</a>). One SNP surpassed Bonferonni-corrected significance (0.05/498,022=1.004×10<sup>-7</sup>). This is an intronic SNP in the <em>VAC14</em> gene (rs875858, minor allele frequency=0.056), which increased neuropathy risk (HR=3.60, 95%CI: 2.21-5.84, p=2.12×10<sup>-8</sup>, <a href="/pmc/articles/PMC5050068/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2A</span></a>). The second and third most strongly associated SNPs were an intergenic SNP (rs11017056, MAF=0.223, HR=2.61, 95%CI: 1.77-3.84, p=3.84×10<sup>-7</sup>) and an intronic SNP in the <em>ATP8A2</em> gene (rs1326116, MAF=0.194, HR=2.77, 95%CI: 1.79-4.27, p=1.77×10<sup>-6</sup>), both of which increased neuropathy risk (<a href="/pmc/articles/PMC5050068/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figures 2B and 2C</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC5050068/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140129479661248" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms782777f1.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms782777f1.jpg" src="/pmc/articles/PMC5050068/bin/nihms782777f1.jpg"></div></a><div id="largeobj_idm140129479661248" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC5050068/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a target="object" href="/pmc/articles/PMC5050068/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC5050068/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Genome-wide association results</strong><p id="__p5">Manhattan plot displaying the unadjusted p-value for the association of cumulative docetaxel dose at grade 3+ sensory neuropathy for all SNPs that passed quality control (n=498,022). One SNP (rs875858) surpassed the Bonferonni-corrected significance threshold of 1.0×10<sup>-7</sup>.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC5050068/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140129479268608" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms782777f2a.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms782777f2a.jpg" src="/pmc/articles/PMC5050068/bin/nihms782777f2a.jpg"></div></a><div id="largeobj_idm140129479268608" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC5050068/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a target="object" href="/pmc/articles/PMC5050068/figure/F2/?report=objectonly">Open in a separate window</a></div><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140129479267760" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms782777f2b.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms782777f2b.jpg" src="/pmc/articles/PMC5050068/bin/nihms782777f2b.jpg"></div><div id="largeobj_idm140129479267760" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5050068/figure/F2/?report=objectonly">Open in a separate window</a></div><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140129479266912" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms782777f2c.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms782777f2c.jpg" src="/pmc/articles/PMC5050068/bin/nihms782777f2c.jpg"></div><div id="largeobj_idm140129479266912" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC5050068/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC5050068/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Incidence of Neuropathy by Genotype for Highly Associated SNPs</strong><p id="__p6">Cumulative incidence curve of docetaxel dose at grade 3+ neuropathy occurrence stratified by genotype for the top three hits: A) a <em>VAC14</em> intronic SNP (rs875858), B) an intergenic SNP (rs11017056), and C) an <em>ATP8A2</em> intronic SNP (rs1326116). In each case, carrying the variant allele increased neuropathy risk compared to wild-type patients, though there were too few patients who were homozygous for the rare VAC14 variant (n=3) to draw meaningful conclusions in this group.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Ten SNPs Most Associated with Neuropathy in GWAS</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140129512716928" class="xtable"><table frame="box" rules="all" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="bottom" align="center">rsID</th><th rowspan="2" colspan="1" valign="bottom" align="center">Chr</th><th rowspan="2" colspan="1" valign="bottom" align="center">Position</th><th rowspan="2" colspan="1" valign="bottom" align="center">Gene</th><th rowspan="2" colspan="1" valign="bottom" align="center">MAF</th><th rowspan="2" colspan="1" valign="bottom" align="center">P-value</th><th rowspan="2" colspan="1" valign="bottom" align="center">HR</th><th rowspan="2" colspan="1" valign="bottom" align="center">95% CI</th><th colspan="2" rowspan="1" valign="bottom" align="center">Adjusted<sup>*</sup></th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="center">P-value</th><th rowspan="1" colspan="1" valign="bottom" align="center">HR</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="bottom" align="center">rs875858</td><td rowspan="1" colspan="1" valign="bottom" align="center">16</td><td rowspan="1" colspan="1" valign="bottom" align="center">69332956</td><td rowspan="1" colspan="1" valign="bottom" align="center">VAC14</td><td rowspan="1" colspan="1" valign="bottom" align="center">0.056</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.12E-08</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.60</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.21-5.84</td><td rowspan="1" colspan="1" valign="bottom" align="center">5.88E-07</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.85</td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">rs11017056</td><td rowspan="1" colspan="1" valign="bottom" align="center">10</td><td rowspan="1" colspan="1" valign="bottom" align="center">131720630</td><td rowspan="1" colspan="1" valign="bottom" align="center">Intergenic</td><td rowspan="1" colspan="1" valign="bottom" align="center">0.223</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.84E-07</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.61</td><td rowspan="1" colspan="1" valign="bottom" align="center">1.77-3.84</td><td rowspan="1" colspan="1" valign="bottom" align="center">6.36E-07</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.58</td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">rs1326116</td><td rowspan="1" colspan="1" valign="bottom" align="center">13</td><td rowspan="1" colspan="1" valign="bottom" align="center">25273046</td><td rowspan="1" colspan="1" valign="bottom" align="center">ATP8A2</td><td rowspan="1" colspan="1" valign="bottom" align="center">0.194</td><td rowspan="1" colspan="1" valign="bottom" align="center">1.77E-06</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.77</td><td rowspan="1" colspan="1" valign="bottom" align="center">1.79-4.27</td><td rowspan="1" colspan="1" valign="bottom" align="center">4.57E-06</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.99</td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">rs8089250</td><td rowspan="1" colspan="1" valign="bottom" align="center">18</td><td rowspan="1" colspan="1" valign="bottom" align="center">4762807</td><td rowspan="1" colspan="1" valign="bottom" align="center">Intergenic</td><td rowspan="1" colspan="1" valign="bottom" align="center">0.175</td><td rowspan="1" colspan="1" valign="bottom" align="center">1.83E-06</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.72</td><td rowspan="1" colspan="1" valign="bottom" align="center">1.78-4.17</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.51E-05</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.49</td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">rs6436559</td><td rowspan="1" colspan="1" valign="bottom" align="center">2</td><td rowspan="1" colspan="1" valign="bottom" align="center">226061042</td><td rowspan="1" colspan="1" valign="bottom" align="center">KIAA1486</td><td rowspan="1" colspan="1" valign="bottom" align="center">0.063</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.62E-06</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.34</td><td rowspan="1" colspan="1" valign="bottom" align="center">1.95-5.71</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.26E-05</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.19</td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">rs11840337</td><td rowspan="1" colspan="1" valign="bottom" align="center">13</td><td rowspan="1" colspan="1" valign="bottom" align="center">25287298</td><td rowspan="1" colspan="1" valign="bottom" align="center">ATP8A2</td><td rowspan="1" colspan="1" valign="bottom" align="center">0.191</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.16E-06</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.71</td><td rowspan="1" colspan="1" valign="bottom" align="center">1.75-4.18</td><td rowspan="1" colspan="1" valign="bottom" align="center">9.26E-06</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.90</td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">rs1566691</td><td rowspan="1" colspan="1" valign="bottom" align="center">5</td><td rowspan="1" colspan="1" valign="bottom" align="center">3780179</td><td rowspan="1" colspan="1" valign="bottom" align="center">Intergenic</td><td rowspan="1" colspan="1" valign="bottom" align="center">0.057</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.63E-06</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.64</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.03-6.52</td><td rowspan="1" colspan="1" valign="bottom" align="center">4.45E-05</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.41</td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">rs1027796</td><td rowspan="1" colspan="1" valign="bottom" align="center">11</td><td rowspan="1" colspan="1" valign="bottom" align="center">132262880</td><td rowspan="1" colspan="1" valign="bottom" align="center">OPCML</td><td rowspan="1" colspan="1" valign="bottom" align="center">0.305</td><td rowspan="1" colspan="1" valign="bottom" align="center">3.90E-06</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.38</td><td rowspan="1" colspan="1" valign="bottom" align="center">1.62-3.48</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.41E-05</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.32</td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">rs2213920</td><td rowspan="1" colspan="1" valign="bottom" align="center">9</td><td rowspan="1" colspan="1" valign="bottom" align="center">117311405</td><td rowspan="1" colspan="1" valign="bottom" align="center">Intergenic</td><td rowspan="1" colspan="1" valign="bottom" align="center">0.128</td><td rowspan="1" colspan="1" valign="bottom" align="center">5.26E-06</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.63</td><td rowspan="1" colspan="1" valign="bottom" align="center">1.70-4.06</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.11E-05</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.66</td></tr><tr><td rowspan="1" colspan="1" valign="bottom" align="center">rs4438470</td><td rowspan="1" colspan="1" valign="bottom" align="center">2</td><td rowspan="1" colspan="1" valign="bottom" align="center">228722963</td><td rowspan="1" colspan="1" valign="bottom" align="center">SPHKAP</td><td rowspan="1" colspan="1" valign="bottom" align="center">0.137</td><td rowspan="1" colspan="1" valign="bottom" align="center">5.47E-06</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.71</td><td rowspan="1" colspan="1" valign="bottom" align="center">1.73-4.25</td><td rowspan="1" colspan="1" valign="bottom" align="center">7.79E-05</td><td rowspan="1" colspan="1" valign="bottom" align="center">2.47</td></tr></tbody></table></div><div id="largeobj_idm140129512716928" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5050068/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p id="__p10" class="p p-first">95% CI: 95% Confidence interval around hazard ratio estimate</p><p id="__p11" class="p">Chr: Chromosome</p><p id="__p12" class="p">HR: Hazard ratio</p><p id="__p13" class="p p-last">MAF: minor allele frequency in the 90401 Caucasian cohort</p></div><div id="TFN2"><sup>*</sup>Adjusted for patient BMI, age, history of diabetes, and treatment arm.</div></div></div><p id="P21" class="p p-last">The associations of all SNPs were then adjusted for treatment arm and several clinical covariates previously reported to be relevant to neuropathy risk including diabetes, age, and BMI. In this particular cohort, among the clinical covariates only increasing age (p=0.0003) was significantly associated with neuropathy, though increasing BMI showed a trend toward association (p=0.05). Covariate adjustment did not substantially affect the results, though the association of <em>VAC14</em> fell below the Bonferonni-corrected significance threshold after adjustment (p=5.88 ×10<sup>-7</sup>). The top 1000 SNPs mapped to 240 unique genes, which were included in the pathway analysis. The three most significantly enriched pathways in the GWAS are displayed in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Table 3</a>. Notably, two of these enriched pathways are relevant to CIPN; Axonal Guidance (p=1.20×10<sup>-4</sup>) and Neuropathic Pain Signaling in Dorsal Horn Neurons (p=6.03×10<sup>-3</sup>).</p></div><div id="S15" class="sec"><h3 id="S15title">Cross-GWAS Pharmacogenetic Replication</h3><p id="P22" class="p p-first-last">Due to the absence of a large cohort of docetaxel-treated patients with prostate cancer in which to perform replication, and our interest in assessing whether taxanes share genetic predictors of neuropathy risk, cross-study pharmacogenetic replication was attempted in a cohort of paclitaxel-treated Caucasian patients with breast cancer enrolled on CALGB (Alliance 40101). The <em>VAC14</em> SNP (rs875858) discovered in our docetaxel-induced neuropathy GWAS was not associated with paclitaxel-induced neuropathy in the 40101 study (p=0.70)(<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886853">9</a>). In addition, SNPs that were discovered in previously published GWAS of paclitaxel-induced neuropathy (<em>FGD4</em> (rs10771973) p=0.39, <em>EPHA4</em> (rs17348202) p=0.76, <em>EPHA5</em> (rs7349683) p=0.15, intergenic (rs3125923) p=0.057, <em>FCAMR</em> (rs1856746) <em>p</em>=0.25) (<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886882">9</a>, <a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886839">10</a>, <a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886891">12</a>) or candidate SNP studies of docetaxel-induced neuropathy (<em>GSTP1</em> Ala114Val (rs1138272) p=0.98, <em>ABCB1</em> 1236C&gt;T (rs1128503) p=0.62, <em>ABCB1</em> (rs4148738) p=0.90, <em>ABCB1</em> 3435C&gt;T (rs1045642) p=0.80) (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886879">13</a>-<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886873">15</a>) were not associated with docetaxel-induced neuropathy occurrence in the CALGB 90401 patients. Finally, when comparing the top SNPs from taxane-induced neuropathy GWAS performed within CALGB 90401 (docetaxel) and 40101 (paclitaxel), there was no statistical evidence that the degree of overlap was greater than would be expected by random chance (data not shown).</p></div><div id="S16" class="sec"><h3 id="S16title">Peripheral Neuronal Cell Sensitivity</h3><p id="P23" class="p p-first-last">To determine the effect of <em>VAC14</em> knockdown on neuronal sensitivity to docetaxel and paclitaxel, commercially available human iPSC-derived peripheral neurons (Peri4.U) were utilized. At the time of image analysis, which is 24 and 48 hours post drug treatment (48 and 72 h post transfection), expression of <em>VAC14</em> in neurons treated with 1 μM siRNA had decreased to 54 and 44%, respectively, as compared to control cells treated with a non-targeting siRNA (<a href="/pmc/articles/PMC5050068/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3B</span></a>). The VAC14 siRNA knockdown at 24 hours post-docetaxel treatment did not affect relative total outgrowth (<a href="/pmc/articles/PMC5050068/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3C</span></a>) in the peripheral neurons but resulted in significantly greater sensitivity to docetaxel as measured by relative number of processes (p=0.0015, <a href="/pmc/articles/PMC5050068/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3D</span></a>) and relative number of branches (p&lt;0.0001, <a href="/pmc/articles/PMC5050068/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3E</span></a>) Similar effects were found in preliminary studies of <em>VAC14</em> knockdown in a human IPSC-derived cortical neuron, iCell<sup>®</sup> Neurons measured 48 hours after treatment (Cellular Dynamics International, Madison, WI) (data not shown). In contrast, <em>VAC14</em> siRNA knockdown significantly decreased peripheral neuronal cell sensitivity to paclitaxel as measured by these same cellular phenotypes (all p&lt;0.05, <a href="/pmc/articles/PMC5050068/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3F-3H</span></a>). Other morphological characteristics including mean process length, mean outgrowth intensity and relative straightness were also measured for docetaxel and paclitaxel (<a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 2</a>). We found a decreased sensitivity to docetaxel and paclitaxel when measuring mean process length and for mean outgrowth intensity for paclitaxel only. There was no difference in measurements of relative straightness (data not shown).</p></div><div id="S17" class="sec sec-last"><h3 id="S17title">Mouse Mechanical Sensitivity</h3><p id="P24" class="p p-first-last">Prior to receiving docetaxel treatment, <em>VAC14</em><sup>+/-</sup> heterozygous mice were more sensitive than wild type <em>VAC14</em><sup>+/+</sup> mice to mechanical stimuli using von Frey filaments (p=0.001, <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Figure 3</a>). When stratified by gender this effect was significant in male mice (p=0.002) but not female mice (p=0.16), however, there was no statistically significant gender interaction (p=0.10). The difference in sensitivity to mechanical stimuli between genotype groups at baseline was attenuated over the course of the experiment in untreated mice, as there was no evidence of a difference between these groups from at the end of the experiment (p=0.23). As expected, 8 days of docetaxel treatment increased sensitivity to mechanical stimuli compared to untreated control mice, regardless of mouse genotype (p&lt;0.0001, <a href="/pmc/articles/PMC5050068/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Figure 4</span></a>). Comparing across genotype groups, there was no difference between <em>VAC14</em><sup>+/-</sup> and <em>VAC14</em><sup>+/+</sup> mice in docetaxel-induced increase in threshold sensitivity to mechanical stimuli at day 8 (p=0.18) or day 14 (p=0.80) when the neuropathy was at its maximum.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC5050068/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140129479258176" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is nihms782777f4.jpg" title="An external file that holds a picture, illustration, etc.
Object name is nihms782777f4.jpg" src="/pmc/articles/PMC5050068/bin/nihms782777f4.jpg"></div></a><div id="largeobj_idm140129479258176" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC5050068/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"></a><a target="object" href="/pmc/articles/PMC5050068/figure/F4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC5050068/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Docetaxel Treatment Increases Nociceptive Sensitivity in <em>VAC14</em> Heterozygous and Wild-type Mice</strong><p id="__p8">The withdrawal threshold is defined as the lightest fiber weight that caused each mouse to withdraw their hind paw at least three times out of five. Each mouse has a withdrawal threshold at each time-point in the study. The mean withdrawal threshold is the average of 12-14 mice (6-7 for each gender) for each treatment condition (VAC14 genotype and docetaxel treatment). Docetaxel- treated mice of either genotype had greater hindpaw withdrawal sensitivity following the end of treatment at day 8 compared to the untreated control mice (p&lt;0.0001). There was no significant difference in the docetaxel-induced increase in withdrawal sensitivity comparing VAC14 heterozygous and wild-type mice (p=0.18).</p></div></div></div></div></div><div id="S18" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S18title">Discussion</h2><p id="P25" class="p p-first">GWAS in a large cohort of mCRPC patients receiving docetaxel treatment identified an intronic SNP (rs875858) within <em>VAC14</em> that was associated with increase neuropathy risk (HR=3.60). <em>VAC14</em> has been directly linked to neurodegeneration in animal models(<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886834">20</a>) and linked to hereditary neuropathy conditions in humans(<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886832">28</a>). The lack of clinical replication in a cohort of paclitaxel-treated breast cancer patients is perhaps due to known differences between the two taxanes, including neuropathy profile(<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886887">29</a>). Distinct genetic modifiers of cellular sensitivity to paclitaxel and docetaxel have been previously reported in <em>in vitro</em> models(<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886859">30</a>) and the results of cellular sensitivity experiments demonstrating that VAC14 knockdown enhances sensitivity of peripheral neurons to docetaxel but not paclitaxel for relative number of processes and relative branching, further support this hypothesis. Given the distinct genetic effects on neuronal sensitivity to docetaxel and paclitaxel it is conceivable that the polymorphisms that affect neuropathy risk also differ between the two taxanes. This would be consistent with the lack of cross-study replication, including the lack of association with docetaxel-induced neuropathy occurrence in this analysis for SNPs (<em>FGD4</em>, <em>EPHA4</em> and <em>EPHA5</em>) that have been previously discovered, and in some cases replicated, in paclitaxel-induced neuropathy GWAS (<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886850">9</a>, <a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886892">10</a>, <a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886837">12</a>, <a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584573278">31</a>). Alternatively, heterogeneity between the patient cohorts, including differences in gender, age, and functional status, or differences in the phenotype (grade 2+ vs. grade 3+), may explain the lack of replication across the clinical GWAS. This GWAS was also not able to replicate previously reported associations between docetaxel-induced neuropathy and SNPs in <em>ABCB1</em>(<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886835">15</a>) or <em>GSTP1</em>(<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886851">13</a>, <a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886852">14</a>) reported in previous candidate SNP studies, similar to the failure of paclitaxel GWAS to replicate associations with candidate SNPs including <em>CYP2C8*3</em>(<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886867">32</a>).</p><p id="P26">The mechanistic importance of VAC14 in docetaxel-induced neuropathy was tested in two pre-clinical models of CIPN. Knockdown of <em>VAC14</em> in the peripheral neuronal cell model (Peri.4U) increased sensitivity to docetaxel treatment as measured by decreased neurite number of processes and neurite branching. Interestingly, knockdown of <em>VAC14</em> seemed to decrease cellular sensitivity to paclitaxel treatment for these morphological characteristics suggesting that this gene may play an important role in the damage to processes and branching induced by docetaxel but not paclitaxel. A similar model of human neuronal cell sensitivity that utilizes induced pluripotent cortical neurons (iCell<sup>®</sup> Neurons) has previously been used for mechanistic validation of GWAS hits that increases risk of paclitaxel-induced neuropathy(<a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886869">19</a>, <a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_584573277">33</a>) and vincristine-induced neuropathy(<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886874">11</a>). These human model systems have several advantages over the use of rodent cell lines such as rat pheochromocytoma cell lines, PC12 or NS1. One major limitation of rodent cell lines is the required treatment with nerve growth factor to initiate nerve outgrowth, which confounds the evaluation of drug treatment effects(<a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886858">34</a>-<a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886877">36</a>).</p><p id="P27">To our knowledge this is the first study to attempt mechanistic validation of a finding from a clinical GWAS in an animal model of CIPN. The Von Frey Filament Test is a well-established rodent model to test sensitivity to nociceptive stimuli, as a surrogate for peripheral neuropathy, that is commonly used for mechanistic investigation of neuropathy(<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886880">21</a>, <a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886868">37</a>, <a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886861">38</a>). Unlike the cell experiment, <em>VAC14</em> heterozygous mice were not more sensitive than wild-type littermates to the effect of docetaxel, but were more sensitive to mechanical stimuli prior to treatment. The enhanced sensitivity in the heterozygous mice at baseline was attenuated over time in the untreated cohort, in both male and female mice. It is possible that these mice acclimate to the discomfort of the mechanical stimuli or they may be experiencing numbness, another characteristic symptom of peripheral neuropathy in taxane-treated patients, though additional experiments would be required to test either hypothesis. It is unclear from these findings whether patients with <em>VAC14</em> polymorphisms have subclinical neuropathy at baseline that is expressed by treatment, as suggested by the mouse data, or whether they are similar at baseline and have greater neuropathy development from docetaxel treatment. Subjective testing that is sensitive for subclinical neuropathy, perhaps with electrophysiological or quantitative sensory assessment(<a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886848">39</a>), in untreated patients with wild-type and polymorphic VAC14 may help resolve this conundrum.</p><p id="P28">The VAC14 protein provides a scaffold for the lipid kinase PIKfyve and its positive regulator, FIG4. These proteins reside in a complex that is responsible for the generation of the signaling lipids phosphatidylinositol (<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886841">3</a>,<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886884">5</a>)-bisphosphate (PI(<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886849">3</a>,<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886866">5</a>)P<sub>2</sub>) and PI5P. These lipids are essential in multiple tissues(<a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886856">28</a>). The inability of VAC14<sup>-/-</sup> homozygous mice to survive beyond 1-2 days after birth necessitated the use of <em>VAC14</em><sup>+/-</sup> heterozygous mice(<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886870">20</a>). On autopsy AC14<sup>-/-</sup> homozygous mice exhibit massive neurodegeneration with cell bodies in the central and peripheral nervous system containing large vacuoles. This neurodegeneration and vacuolization are similar to that found in FIG4 null mice, suggesting that variation in these genes is likely to phenocopy in humans as well as in mice(<a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886878">40</a>). A rare mutation in the FIG4 gene is known to cause a subtype of Charcot-Marie-Tooth disease, a hereditary neuropathy syndrome(<a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886883">41</a>). Interestingly, the CALGB 40101 paclitaxel-induced neuropathy GWAS discovered and replicated an association for a SNP in <em>FGD4</em> (rs10771973), another gene known to cause Charcot-Marie-Tooth disease(<a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886844">42</a>), though this variant was not associated with docetaxel-induced neuropathy in our CALGB 90401 cohort.</p><p id="P29">The SNP (rs875858) discovered in this GWAS lies within an intron of the <em>VAC14</em> gene. It is unclear what effect, if any, this individual SNP has on VAC14 expression or activity in the peripheral neuron. In the GTEx database there is no association between rs875858 and <em>VAC14</em> gene expression in the tibial nerve tissue, though the power of this analysis is limited by the relatively small number of samples (n=256) and low minor allele frequency (MAF=0.06) of this SNP <a href="http://www.gtexportal.org/home/eqtls/bySnp?snpId=rs875858&amp;tissueName=Nerve_Tibial" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.gtexportal.org/home/eqtls/bySnp?snpId=rs875858&amp;tissueName=Nerve_Tibial</a>. In the larger DGN cohort (n=922), rs875858 is highly associated with IL34 (p=4e-7) expression in whole blood. IL-34 is structurally similar to colony-stimulating factor 1 and both are ligands of the colony-stimulating factor 1 receptor(<a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886855">43</a>), which has recently been identified as an efficacious target in mouse models of Charcot-Marie-Tooth disease(<a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886838">44</a>), providing an alternative plausible biological mechanism for this association. Finally, it is conceivable that this SNP is not functionally relevant but instead is a genetic marker of a different causative SNP; however, rs875858 lies in a region of low linkage disequilibrium.</p><p id="P30">The SNP (rs1326116) with the third strongest association with docetaxel-induced neuropathy is an intronic polymorphism in the <em>ATP8A2</em> gene, which encodes ATP8A2, a P4 ATPase. The P-type ATPases are a superfamily of proteins that translocate phospholipids between the two leaflets of cellular lipid bilayers(<a href="#R45" rid="R45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886860">45</a>). Several lines of evidence link ATP8A2 to neurological development and function; in vitro data that ATP8A2 overexpression enhances neurite outgrowth(<a href="#R46" rid="R46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886836">46</a>), animal data that <em>ATP8A2</em> mutations cause overt progressive neurodegeneration in Wabbler-lethal mice by disrupting axonal transport and polarity(<a href="#R47" rid="R47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886871">47</a>), and case reports of <em>ATP8A2</em> mutations causing severe neurological phenotypes in patients(<a href="#R48" rid="R48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886846">48</a>, <a href="#R49" rid="R49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886888">49</a>).</p><p id="P31">The three pathways most highly enriched in the GWAS results include axonal guidance and neuropathic pain signaling, both of which have obvious relevance to taxane-induced peripheral neuropathy. Growth and maintenance of neuronal axons requires organization of microtubules into a cytoskeleton(<a href="#R50" rid="R50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886854">50</a>). Taxanes stabilize microtubules, potentially interfering with cytoskeletal organization leading to the overt neuropathic symptoms reported by patients. Enrichment in a similar pathway, axonal outgrowth, was reported in a secondary analysis of a paclitaxel-induced neuropathy GWAS, suggesting that these two studies are identifying similar genetic signatures(<a href="#R51" rid="R51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886895">51</a>), despite the lack of overlap of individual SNPs in the top 1000 hits. Neuropathic pain is one of the characteristic clinical manifestations of taxane-induced neuropathy, in addition to sensory and motor components(<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886829">2</a>). Neuropathic pain signaling in the dorsal horn neurons may contribute to taxane-induced peripheral neuropathy via a higher propensity for development of central sensitization(<a href="#R52" rid="R52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886845">52</a>).</p><p id="P32">The primary limitation of this study is the lack of availability of an independent clinical trial cohort of docetaxel-treated patients for pharmacogenetic replication. Another limitation is the reliance on the protocol-specified collection of severe peripheral neuropathy (grade 3 or higher), rather than systematic collection across all toxicity grades. It is possible that some patients experienced grade 2 neuropathy without progressing to grade 3, and thus were not included as neuropathy events in this analysis. Furthermore, ordinal analysis across all neuropathy grades (0-4) would have brought greater statistical power and may have identified a distinct set of SNPs that predict neuropathy severity, similar to the paclitaxel-induced neuropathy GWAS findings in CALGB (Alliance) 40101(<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_561886894">9</a>). The lack of grade 1 or 2 neuropathy data collection may explain the absence of events in the patients homozygous for the rs875858 SNP. However, two of these patients discontinued docetaxel treatment quite early, after 6 (442 mg/m<sup>2</sup>) and 8 (561 mg/m<sup>2</sup>) cycles for progression and grade 3 nausea/vomiting, respectively. The third patient was discontinued after 26 cycles (1,746 mg/m<sup>2</sup>) for a constellation of grade 3 toxicities including cough, dyspnea, fatigue, febrile neutropenia, and pneumonitis, without any documentation of peripheral neuropathy during treatment. The collection of DNA and comprehensive baseline and outcomes data, including accurate assessment of timing and severity of peripheral neuropathy, in other large clinical cohorts will allow for independent replication of our findings.</p><p id="P33" class="p p-last">In conclusion, GWAS of a prospectively enrolled patient cohort identified a SNP in <em>VAC14</em> that predicts sensitivity to docetaxel-induced peripheral neuropathy. <em>VAC14</em> heterozygous mice were subsequently shown to be more sensitive to nociceptive stimuli at baseline, and peripheral neuronal cell (Peri.4U) sensitivity to docetaxel is enhanced after VAC14 knockdown, providing mechanistic validation of the relevance of VAC14 to docetaxel-induced neuropathy. However, the relatively low hazard ratio of this SNP suggests that no single variant or gene is responsible for dictating neuropathy sensitivity or will be clinically useful for personalizing docetaxel treatment. This is consistent with the multifactorial nature of neuropathy that depends on both drug exposure and a variety of patient factors, including age and BMI, which were associated with neuropathy occurrence in this cohort. Replication of the influence of our top candidate SNPs on neuropathy risk in a similar clinical trial cohort of docetaxel-treated mCRPC patients is of great interest to validate the role of these genes and provide support for further investigation into this mechanism for chemotherapy-induced neuropathy prevention or treatment.</p></div><div id="unreferenced-ft" class="tsec sec headless whole_rhythm"><div class="unreferenced">​
                    <div class="boxed-text-box whole_rhythm hide-overflow" id="BX1"><div class="caption"><h3 id="idm140129474303904title">Statement of Translational Relevance</h3></div><p id="__p15">The taxanes are a class of chemotherapeutic agents that are commonly associated with treatment-limiting peripheral sensory neuropathy. Genetic predictors of paclitaxel-induced neuropathy have been discovered but little is known about whether similar genetic factors are associated with risk of docetaxel-induced neuropathy. Discovery of genetic predictors of docetaxel-induced neuropathy could inform personalized treatment decisions to maximize efficacy and avoid unnecessary toxicity. We conducted a genome-wide association study in a large cohort of Caucasian men with hormone refractory prostate cancer treated with docetaxel. One single nucleotide polymorphism in <em>VAC14</em> that was significantly associated with docetaxel-induced neuropathy was then mechanistically validated in cellular and animal models of neurotoxicity. These finding suggest that distinct genetic variants influence risk of peripheral neuropathy from paclitaxel and docetaxel. The genetic variant identified in this study could be useful for understanding the mechanism of docetaxel-induced neuropathy and may be informative for avoiding docetaxel treatment in patients at elevated neuropathy risk.</p></div></div></div><div id="S19" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S19title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="d37e1152"><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-1.png" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(112K, png)</sup></div></div><div class="sec suppmat" id="SD2"><h4>2</h4><div class="sup-box half_rhythm" id="d37e1156"><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-2.jpg" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(44K, jpg)</sup></div></div><div class="sec suppmat" id="SD3"><h4>3</h4><div class="sup-box half_rhythm" id="d37e1160"><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-3.png" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(19K, png)</sup></div></div><div class="sec suppmat" id="SD4"><h4>4</h4><div class="sup-box half_rhythm" id="d37e1164"><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-4.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(49K, doc)</sup></div></div><div class="sec suppmat" id="SD5"><h4>5</h4><div class="sup-box half_rhythm" id="d37e1168"><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-5.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(1.1M, doc)</sup></div></div><div class="sec suppmat" id="SD6"><h4>6</h4><div class="sup-box half_rhythm" id="d37e1172"><a href="/pmc/articles/PMC5050068/bin/NIHMS782777-supplement-6.docx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(14K, docx)</sup></div></div></div><div id="S20" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S20title">Acknowledgments</h2><div class="sec"><p id="__p1">Susan Halabi received research funding from Sanofi. Mark Ratain has served as a paid consultant for Sanofi-Aventis and Genentech. Howard McLeod serves on the Scientific Advisory Board for Cancer Genetics Inc. M. Eileen Dolan has received research funding from Insys Therapeutics. Phillip Febbo received honoraria from Sanofi and is now an employee of Genomic Health.</p><p id="__p2"><strong>Support</strong>: This study was supported by the NIH National Institute of General Medical Sciences Grant U01 GM61390, NIH/National Institute of General Medical Sciences (NIGMS) Pharmacogenomics of Anticancer Agents grant U01GM61393, NIH/National Institute of Nursing Research (NINR) P30NR014129, ALLIANCE grants (CA31946 and CA33601) and ECOG-ACRIN grants (CA21115 and CA16116). This work is part of the NIH PGRN-RIKEN Center for Genomic Medicine Global Alliance. Daniel Hertz was an American Foundation for Pharmaceutical Education Pre-Doctoral Fellow in Clinical Pharmaceutical Science when working on this analysis. Also supported in part by funds from U10CA031983, U10CA060138, U10CA047577, U10CA180838, U10CA180857 and Genentech. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p></div></div><div id="idm140129472664256" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140129472664256title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"></p><p id="__p3" class="p p-first-last"><strong>Conflict of Interest</strong>: The authors declare the following relevant conflicts of interest.</p><p></p><p class="fn sec" id="FN3"></p><p id="__p4" class="p p-first-last"><strong>Previous Reports</strong>: This study was presented in part at the 2013 American Society of Clinical Oncology Annual Meeting. This report contains original material that has not been previously reported.</p><p></p></div></div><div id="idm140129472661136" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140129472661136title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Manfredi JJ, Parness J, Horwitz SB. Taxol binds to cellular microtubules. <span><span class="ref-journal">J Cell Biol. </span>1982 Sep;<span class="ref-vol">94</span>(3):688–96.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2112233/">PMC free article</a>]</span> [<a href="/pubmed/6127342" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biol&amp;title=Taxol+binds+to+cellular+microtubules&amp;author=JJ+Manfredi&amp;author=J+Parness&amp;author=SB+Horwitz&amp;volume=94&amp;issue=3&amp;publication_year=1982&amp;pages=688-96&amp;pmid=6127342&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Lee JJ, Swain SM. Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents. <span><span class="ref-journal">J Clin Oncol. </span>2006 Apr 01;<span class="ref-vol">24</span>(10):1633–42.</span> [<a href="/pubmed/16575015" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Peripheral+Neuropathy+Induced+by+Microtubule-Stabilizing+Agents&amp;author=JJ+Lee&amp;author=SM+Swain&amp;volume=24&amp;issue=10&amp;publication_year=2006&amp;pages=1633-42&amp;pmid=16575015&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Postma TJ, Vermorken JB, Liefting AJM, Pinedo HM, Heimans JJ. Paclitaxel-induced neuropathy. <span><span class="ref-journal">Ann Oncol. </span>1995 May 1;<span class="ref-vol">6</span>(5):489–94.</span> [<a href="/pubmed/7669713" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&amp;title=Paclitaxel-induced+neuropathy&amp;author=TJ+Postma&amp;author=JB+Vermorken&amp;author=AJM+Liefting&amp;author=HM+Pinedo&amp;author=JJ+Heimans&amp;volume=6&amp;issue=5&amp;publication_year=1995&amp;pages=489-94&amp;pmid=7669713&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. <span><span class="ref-journal">J Clin Oncol. </span>2013 Jul 20;<span class="ref-vol">31</span>(21):2699–707.</span> [<a href="/pubmed/23775951" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Chemotherapy-induced+neuropathy+and+its+association+with+quality+of+life+among+2-+to+11-year+colorectal+cancer+survivors:+results+from+the+population-based+PROFILES+registry&amp;author=F+Mols&amp;author=T+Beijers&amp;author=V+Lemmens&amp;author=CJ+van+den+Hurk&amp;author=G+Vreugdenhil&amp;volume=31&amp;issue=21&amp;publication_year=2013&amp;pages=2699-707&amp;pmid=23775951&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">van Gerven JMA, Moll JWB, van den Bent MJ, Bontenbal M, van der Burg MEL, Verweij J, et al.  Paclitaxel (Taxol) induces cumulative mild neurotoxicity. <span><span class="ref-journal">Eur J Cancer. </span>1994;<span class="ref-vol">30</span>(8):1074–7.</span> [<a href="/pubmed/7654432" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cancer&amp;title=Paclitaxel+(Taxol)+induces+cumulative+mild+neurotoxicity&amp;author=JMA+van+Gerven&amp;author=JWB+Moll&amp;author=MJ+van+den+Bent&amp;author=M+Bontenbal&amp;author=MEL+van+der+Burg&amp;volume=30&amp;issue=8&amp;publication_year=1994&amp;pages=1074-7&amp;pmid=7654432&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Mielke S, Sparreboom A, Steinberg SM, Gelderblom H, Unger C, Behringer D, et al.  Association of Paclitaxel Pharmacokinetics with the Development of Peripheral Neuropathy in Patients with Advanced Cancer. <span><span class="ref-journal">Clin Cancer Res. </span>2005 Jul 1;<span class="ref-vol">11</span>(13):4843–50.</span> [<a href="/pubmed/16000582" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Association+of+Paclitaxel+Pharmacokinetics+with+the+Development+of+Peripheral+Neuropathy+in+Patients+with+Advanced+Cancer&amp;author=S+Mielke&amp;author=A+Sparreboom&amp;author=SM+Steinberg&amp;author=H+Gelderblom&amp;author=C+Unger&amp;volume=11&amp;issue=13&amp;publication_year=2005&amp;pages=4843-50&amp;pmid=16000582&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Akerley W, Herndon JE, Egorin MJ, Lyss AP, Kindler HL, Savarese DM, et al.  Weekly, high-dose paclitaxel in advanced lung carcinoma. <span><span class="ref-journal">Cancer. </span>2003;<span class="ref-vol">97</span>(10):2480–6.</span> [<a href="/pubmed/12733147" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Weekly,+high-dose+paclitaxel+in+advanced+lung+carcinoma&amp;author=W+Akerley&amp;author=JE+Herndon&amp;author=MJ+Egorin&amp;author=AP+Lyss&amp;author=HL+Kindler&amp;volume=97&amp;issue=10&amp;publication_year=2003&amp;pages=2480-6&amp;pmid=12733147&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC. Clinical toxicities encountered with paclitaxel (Taxol) <span><span class="ref-journal">Semin Oncol. </span>1993 Aug;<span class="ref-vol">20</span>(4 Suppl 3):1–15.</span> [<a href="/pubmed/8102012" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Oncol&amp;title=Clinical+toxicities+encountered+with+paclitaxel+(Taxol)&amp;author=EK+Rowinsky&amp;author=EA+Eisenhauer&amp;author=V+Chaudhry&amp;author=SG+Arbuck&amp;author=RC+Donehower&amp;volume=20&amp;issue=4+Suppl+3&amp;publication_year=1993&amp;pages=1-15&amp;pmid=8102012&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, et al.  A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. <span><span class="ref-journal">Clin Cancer Res. </span>2012 Sep 15;<span class="ref-vol">18</span>(18):5099–109.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3445665/">PMC free article</a>]</span> [<a href="/pubmed/22843789" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=A+genome-wide+association+study+identifies+novel+loci+for+paclitaxel-induced+sensory+peripheral+neuropathy+in+CALGB+40101&amp;author=RM+Baldwin&amp;author=K+Owzar&amp;author=H+Zembutsu&amp;author=A+Chhibber&amp;author=M+Kubo&amp;volume=18&amp;issue=18&amp;publication_year=2012&amp;pages=5099-109&amp;pmid=22843789&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Leandro-Garcia LJ, Inglada-Perez L, Pita G, Hjerpe E, Leskela S, Jara C, et al.  Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy. <span><span class="ref-journal">J Med Genet. </span>2013 Sep;<span class="ref-vol">50</span>(9):599–605.</span> [<a href="/pubmed/23776197" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Genet&amp;title=Genome-wide+association+study+identifies+ephrin+type+A+receptors+implicated+in+paclitaxel+induced+peripheral+sensory+neuropathy&amp;author=LJ+Leandro-Garcia&amp;author=L+Inglada-Perez&amp;author=G+Pita&amp;author=E+Hjerpe&amp;author=S+Leskela&amp;volume=50&amp;issue=9&amp;publication_year=2013&amp;pages=599-605&amp;pmid=23776197&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, et al.  Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. <span><span class="ref-journal">JAMA. </span>2015 Feb 24;<span class="ref-vol">313</span>(8):815–23.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4377066/">PMC free article</a>]</span> [<a href="/pubmed/25710658" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Association+of+an+inherited+genetic+variant+with+vincristine-related+peripheral+neuropathy+in+children+with+acute+lymphoblastic+leukemia&amp;author=B+Diouf&amp;author=KR+Crews&amp;author=G+Lew&amp;author=D+Pei&amp;author=C+Cheng&amp;volume=313&amp;issue=8&amp;publication_year=2015&amp;pages=815-23&amp;pmid=25710658&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Schneider BP, Li L, Radovich M, Shen F, Miller KD, Flockhart DA, et al.  Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199. <span><span class="ref-journal">Clin Cancer Res. </span>2015 Nov 15;<span class="ref-vol">21</span>(22):5082–91.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4717479/">PMC free article</a>]</span> [<a href="/pubmed/26138065" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Genome-Wide+Association+Studies+for+Taxane-Induced+Peripheral+Neuropathy+in+ECOG-5103+and+ECOG-1199&amp;author=BP+Schneider&amp;author=L+Li&amp;author=M+Radovich&amp;author=F+Shen&amp;author=KD+Miller&amp;volume=21&amp;issue=22&amp;publication_year=2015&amp;pages=5082-91&amp;pmid=26138065&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Mir O, Alexandre J, Tran A, Durand J, Pons G, Treluyer J, et al.  Relationship between GSTP1 Ile105Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity. <span><span class="ref-journal">Ann Oncol. </span>2009 Apr 1;<span class="ref-vol">20</span>(4):736–40.</span> [<a href="/pubmed/19223573" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&amp;title=Relationship+between+GSTP1+Ile105Val+polymorphism+and+docetaxel-induced+peripheral+neuropathy:+clinical+evidence+of+a+role+of+oxidative+stress+in+taxane+toxicity&amp;author=O+Mir&amp;author=J+Alexandre&amp;author=A+Tran&amp;author=J+Durand&amp;author=G+Pons&amp;volume=20&amp;issue=4&amp;publication_year=2009&amp;pages=736-40&amp;pmid=19223573&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Eckhoff L, Feddersen S, Knoop AS, Ewertz M, Bergmann TK. Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancer. <span><span class="ref-journal">Acta Oncol. </span>2015 Apr;<span class="ref-vol">54</span>(4):530–7.</span> [<a href="/pubmed/25383449" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Oncol&amp;title=Docetaxel-induced+neuropathy:+a+pharmacogenetic+case-control+study+of+150+women+with+early-stage+breast+cancer&amp;author=L+Eckhoff&amp;author=S+Feddersen&amp;author=AS+Knoop&amp;author=M+Ewertz&amp;author=TK+Bergmann&amp;volume=54&amp;issue=4&amp;publication_year=2015&amp;pages=530-7&amp;pmid=25383449&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Sissung TM, Baum CE, Deeken J, Price DK, Aragon-Ching J, Steinberg SM, et al.  ABCB1 Genetic Variation Influences the Toxicity and Clinical Outcome of Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel. <span><span class="ref-journal">Clin Cancer Res. </span>2008 Jul 15;<span class="ref-vol">14</span>(14):4543–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2723795/">PMC free article</a>]</span> [<a href="/pubmed/18628469" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=ABCB1+Genetic+Variation+Influences+the+Toxicity+and+Clinical+Outcome+of+Patients+with+Androgen-Independent+Prostate+Cancer+Treated+with+Docetaxel&amp;author=TM+Sissung&amp;author=CE+Baum&amp;author=J+Deeken&amp;author=DK+Price&amp;author=J+Aragon-Ching&amp;volume=14&amp;issue=14&amp;publication_year=2008&amp;pages=4543-9&amp;pmid=18628469&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Kelly WK, Halabi S, Carducci M, George D, Mahoney JF, Stadler WM, et al.  Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401. <span><span class="ref-journal">J Clin Oncol. </span>2012 May 01;<span class="ref-vol">30</span>(13):1534–40.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3383121/">PMC free article</a>]</span> [<a href="/pubmed/22454414" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Randomized,+Double-Blind,+Placebo-Controlled+Phase+III+Trial+Comparing+Docetaxel+and+Prednisone+With+or+Without+Bevacizumab+in+Men+With+Metastatic+Castration-Resistant+Prostate+Cancer:+CALGB+90401&amp;author=WK+Kelly&amp;author=S+Halabi&amp;author=M+Carducci&amp;author=D+George&amp;author=JF+Mahoney&amp;volume=30&amp;issue=13&amp;publication_year=2012&amp;pages=1534-40&amp;pmid=22454414&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Fine JP, Gray RJ. A Proportional Hazards Model for the Subdistribution of a Competing Risk. <span><span class="ref-journal">JASA. </span>1999 Jun 01;<span class="ref-vol">94</span>(446):496–509.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JASA&amp;title=A+Proportional+Hazards+Model+for+the+Subdistribution+of+a+Competing+Risk&amp;author=JP+Fine&amp;author=RJ+Gray&amp;volume=94&amp;issue=446&amp;publication_year=1999&amp;pages=496-509&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Prentice RL, Kalbfleisch JD, Peterson AV, Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. <span><span class="ref-journal">Biometrics. </span>1978 Dec;<span class="ref-vol">34</span>(4):541–54.</span> [<a href="/pubmed/373811" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biometrics&amp;title=The+analysis+of+failure+times+in+the+presence+of+competing+risks&amp;author=RL+Prentice&amp;author=JD+Kalbfleisch&amp;author=AV+Peterson&amp;author=N+Flournoy&amp;author=VT+Farewell&amp;volume=34&amp;issue=4&amp;publication_year=1978&amp;pages=541-54&amp;pmid=373811&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Wheeler HE, Wing C, Delaney SM, Komatsu M, Dolan ME. Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells. <span><span class="ref-journal">PLoS One. </span>2015 Feb 17;<span class="ref-vol">10</span>(2):e0118020.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4331516/">PMC free article</a>]</span> [<a href="/pubmed/25689802" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Modeling+chemotherapeutic+neurotoxicity+with+human+induced+pluripotent+stem+cell-derived+neuronal+cells&amp;author=HE+Wheeler&amp;author=C+Wing&amp;author=SM+Delaney&amp;author=M+Komatsu&amp;author=ME+Dolan&amp;volume=10&amp;issue=2&amp;publication_year=2015&amp;pages=e0118020&amp;pmid=25689802&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Zhang Y, Zolov SN, Chow CY, Slutsky SG, Richardson SC, Piper RC, et al.  Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2007 Oct 30;<span class="ref-vol">104</span>(44):17518–23.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2077288/">PMC free article</a>]</span> [<a href="/pubmed/17956977" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=Loss+of+Vac14,+a+regulator+of+the+signaling+lipid+phosphatidylinositol+3,5-bisphosphate,+results+in+neurodegeneration+in+mice&amp;author=Y+Zhang&amp;author=SN+Zolov&amp;author=CY+Chow&amp;author=SG+Slutsky&amp;author=SC+Richardson&amp;volume=104&amp;issue=44&amp;publication_year=2007&amp;pages=17518-23&amp;pmid=17956977&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Renn CL, Carozzi VA, Rhee P, Gallop D, Dorsey SG, Cavaletti G. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. <span><span class="ref-journal">Mol Pain. </span>2011 Apr 26;<span class="ref-vol">7</span>:29.</span> 8069-7-29. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3105941/">PMC free article</a>]</span> [<a href="/pubmed/21521528" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Pain&amp;title=Multimodal+assessment+of+painful+peripheral+neuropathy+induced+by+chronic+oxaliplatin-based+chemotherapy+in+mice&amp;author=CL+Renn&amp;author=VA+Carozzi&amp;author=P+Rhee&amp;author=D+Gallop&amp;author=SG+Dorsey&amp;volume=7&amp;publication_year=2011&amp;pages=29&amp;pmid=21521528&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Shulman LN, Cirrincione CT, Berry DA, Becker HP, Perez EA, O'Regan R, et al.  Six Cycles of Doxorubicin and Cyclophosphamide or Paclitaxel Are Not Superior to Four Cycles As Adjuvant Chemotherapy for Breast Cancer in Women With Zero to Three Positive Axillary Nodes: Cancer and Leukemia Group B 40101. <span><span class="ref-journal">J Clin Oncol. </span>2012 Nov 20;<span class="ref-vol">30</span>(33):4071–6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3494835/">PMC free article</a>]</span> [<a href="/pubmed/22826271" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Six+Cycles+of+Doxorubicin+and+Cyclophosphamide+or+Paclitaxel+Are+Not+Superior+to+Four+Cycles+As+Adjuvant+Chemotherapy+for+Breast+Cancer+in+Women+With+Zero+to+Three+Positive+Axillary+Nodes:+Cancer+and+Leukemia+Group+B+40101&amp;author=LN+Shulman&amp;author=CT+Cirrincione&amp;author=DA+Berry&amp;author=HP+Becker&amp;author=EA+Perez&amp;volume=30&amp;issue=33&amp;publication_year=2012&amp;pages=4071-6&amp;pmid=22826271&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">R Development Core Team. <span class="ref-journal">R: A language and environment for statistical computing.</span> R Foundation for Statistical Computing; Vienna, Austria: 2008.  URL  <a href="http://www.R-project.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.R-project.org</a>. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=R:+A+language+and+environment+for+statistical+computing&amp;publication_year=2008&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Therneau T, Grambsch P.  <span class="ref-journal">Modeling Survival Data: Extending the Cox Model.</span> New York, New York: Springer-Verlag; 2000.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Modeling+Survival+Data:+Extending+the+Cox+Model&amp;author=T+Therneau&amp;author=P+Grambsch&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Aulchenko YS, Ripke S, Isaacs A, van Duijn CM. GenABEL: an R library for genome-wide association analysis. <span><span class="ref-journal">Bioinformatics. </span>2007 May 15;<span class="ref-vol">23</span>(10):1294–6.</span> [<a href="/pubmed/17384015" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=GenABEL:+an+R+library+for+genome-wide+association+analysis&amp;author=YS+Aulchenko&amp;author=S+Ripke&amp;author=A+Isaacs&amp;author=CM+van+Duijn&amp;volume=23&amp;issue=10&amp;publication_year=2007&amp;pages=1294-6&amp;pmid=17384015&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Filleron T, Laplanche A, Boher JM, Kramar A. An R function to non-parametric and piecewise analysis of competing risks survival data. <span><span class="ref-journal">Comput Methods Programs Biomed. </span>2010 Oct;<span class="ref-vol">100</span>(1):24–38.</span> [<a href="/pubmed/20338662" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Comput+Methods+Programs+Biomed&amp;title=An+R+function+to+non-parametric+and+piecewise+analysis+of+competing+risks+survival+data&amp;author=T+Filleron&amp;author=A+Laplanche&amp;author=JM+Boher&amp;author=A+Kramar&amp;volume=100&amp;issue=1&amp;publication_year=2010&amp;pages=24-38&amp;pmid=20338662&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Fay MP, Shaw PA. Exact and Asymptotic Weighted Logrank Tests for Interval Censored Data: The interval R package. <span><span class="ref-journal">J Stat Softw. </span>2010 Aug;<span class="ref-vol">36</span>(2):i02.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4184046/">PMC free article</a>]</span> [<a href="/pubmed/25285054" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Stat+Softw&amp;title=Exact+and+Asymptotic+Weighted+Logrank+Tests+for+Interval+Censored+Data:+The+interval+R+package&amp;author=MP+Fay&amp;author=PA+Shaw&amp;volume=36&amp;issue=2&amp;publication_year=2010&amp;pages=i02&amp;pmid=25285054&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Zolov SN, Bridges D, Zhang Y, Lee W, Riehle E, Verma R, et al.  In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2012 Oct 23;<span class="ref-vol">109</span>(43):17472–7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3491506/">PMC free article</a>]</span> [<a href="/pubmed/23047693" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+U+S+A&amp;title=In+vivo,+Pikfyve+generates+PI(3,5)P2,+which+serves+as+both+a+signaling+lipid+and+the+major+precursor+for+PI5P&amp;author=SN+Zolov&amp;author=D+Bridges&amp;author=Y+Zhang&amp;author=W+Lee&amp;author=E+Riehle&amp;volume=109&amp;issue=43&amp;publication_year=2012&amp;pages=17472-7&amp;pmid=23047693&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Takemoto S, Ushijima K, Honda K, Wada H, Terada A, Imaishi H, et al.  Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel-carboplatin and docetaxel-carboplatin therapy. <span><span class="ref-journal">Int J Clin Oncol. </span>2012 Aug;<span class="ref-vol">17</span>(4):367–72.</span> [<a href="/pubmed/21850385" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Clin+Oncol&amp;title=Precise+evaluation+of+chemotherapy-induced+peripheral+neuropathy+using+the+visual+analogue+scale:+a+quantitative+and+comparative+analysis+of+neuropathy+occurring+with+paclitaxel-carboplatin+and+docetaxel-carboplatin+therapy&amp;author=S+Takemoto&amp;author=K+Ushijima&amp;author=K+Honda&amp;author=H+Wada&amp;author=A+Terada&amp;volume=17&amp;issue=4&amp;publication_year=2012&amp;pages=367-72&amp;pmid=21850385&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Niu N, Schaid D, Abo R, Kalari K, Fridley B, Feng Q, et al.  Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study. <span><span class="ref-journal">BMC Cancer. </span>2012 Sep 24;<span class="ref-vol">12</span>(1):422.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3573965/">PMC free article</a>]</span> [<a href="/pubmed/23006423" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Cancer&amp;title=Genetic+association+with+overall+survival+of+taxane-treated+lung+cancer+patients+-+A+genome-wide+association+study+in+human+lymphoblastoid+cell+lines+followed+by+a+clinical+association+study&amp;author=N+Niu&amp;author=D+Schaid&amp;author=R+Abo&amp;author=K+Kalari&amp;author=B+Fridley&amp;volume=12&amp;issue=1&amp;publication_year=2012&amp;pages=422&amp;pmid=23006423&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Abraham JE, Guo Q, Dorling L, Tyrer J, Ingle S, Hardy R, et al.  Replication of Genetic Polymorphisms Reported to be Associated with Taxane-Related Sensory Neuropathy in Early Breast Cancer Patients treated with Paclitaxel. <span><span class="ref-journal">Clinical Cancer Research. </span>2014 Mar 05;</span> [<a href="/pubmed/24599932" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clinical+Cancer+Research&amp;title=Replication+of+Genetic+Polymorphisms+Reported+to+be+Associated+with+Taxane-Related+Sensory+Neuropathy+in+Early+Breast+Cancer+Patients+treated+with+Paclitaxel&amp;author=JE+Abraham&amp;author=Q+Guo&amp;author=L+Dorling&amp;author=J+Tyrer&amp;author=S+Ingle&amp;publication_year=2014&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Hertz DL, Roy S, Motsinger-Reif AA, Drobish A, Clark LS, McLeod HL, et al.  CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel. <span><span class="ref-journal">Ann Oncol. </span>2013 Jun;<span class="ref-vol">24</span>(6):1472–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3660078/">PMC free article</a>]</span> [<a href="/pubmed/23413280" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Oncol&amp;title=CYP2C8*3+increases+risk+of+neuropathy+in+breast+cancer+patients+treated+with+paclitaxel&amp;author=DL+Hertz&amp;author=S+Roy&amp;author=AA+Motsinger-Reif&amp;author=A+Drobish&amp;author=LS+Clark&amp;volume=24&amp;issue=6&amp;publication_year=2013&amp;pages=1472-8&amp;pmid=23413280&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Komatsu M, Wheeler HE, Chung S, Low SK, Wing C, Delaney SM, et al.  Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy. <span><span class="ref-journal">Clin Cancer Res. </span>2015 May 26;</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4592389/">PMC free article</a>]</span> [<a href="/pubmed/26015512" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Pharmacoethnicity+in+Paclitaxel-Induced+Sensory+Peripheral+Neuropathy&amp;author=M+Komatsu&amp;author=HE+Wheeler&amp;author=S+Chung&amp;author=SK+Low&amp;author=C+Wing&amp;publication_year=2015&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Rovini A, Carre M, Bordet T, Pruss RM, Braguer D. Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells. <span><span class="ref-journal">Biochem Pharmacol. </span>2010 Sep 15;<span class="ref-vol">80</span>(6):884–94.</span> [<a href="/pubmed/20417191" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Pharmacol&amp;title=Olesoxime+prevents+microtubule-targeting+drug+neurotoxicity:+selective+preservation+of+EB+comets+in+differentiated+neuronal+cells&amp;author=A+Rovini&amp;author=M+Carre&amp;author=T+Bordet&amp;author=RM+Pruss&amp;author=D+Braguer&amp;volume=80&amp;issue=6&amp;publication_year=2010&amp;pages=884-94&amp;pmid=20417191&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Verstappen CC, Postma TJ, Geldof AA, Heimans JJ. Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation. <span><span class="ref-journal">Anticancer Res. </span>2004 Jul-Aug;<span class="ref-vol">24</span>(4):2337–41.</span> [<a href="/pubmed/15330181" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer+Res&amp;title=Amifostine+protects+against+chemotherapy-induced+neurotoxicity:+an+in+vitro+investigation&amp;author=CC+Verstappen&amp;author=TJ+Postma&amp;author=AA+Geldof&amp;author=JJ+Heimans&amp;volume=24&amp;issue=4&amp;publication_year=2004&amp;pages=2337-41&amp;pmid=15330181&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Kawashiri T, Egashira N, Itoh Y, Shimazoe T, Ikegami Y, Yano T, et al.  Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy. <span><span class="ref-journal">Eur J Cancer. </span>2009 Jan;<span class="ref-vol">45</span>(1):154–63.</span> [<a href="/pubmed/19027286" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cancer&amp;title=Neurotropin+reverses+paclitaxel-induced+neuropathy+without+affecting+anti-tumour+efficacy&amp;author=T+Kawashiri&amp;author=N+Egashira&amp;author=Y+Itoh&amp;author=T+Shimazoe&amp;author=Y+Ikegami&amp;volume=45&amp;issue=1&amp;publication_year=2009&amp;pages=154-63&amp;pmid=19027286&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Hoke A, Ray M. Rodent models of chemotherapy-induced peripheral neuropathy. <span><span class="ref-journal">ILAR J. </span>2014;<span class="ref-vol">54</span>(3):273–81.</span> [<a href="/pubmed/24615440" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=ILAR+J&amp;title=Rodent+models+of+chemotherapy-induced+peripheral+neuropathy&amp;author=A+Hoke&amp;author=M+Ray&amp;volume=54&amp;issue=3&amp;publication_year=2014&amp;pages=273-81&amp;pmid=24615440&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. <span><span class="ref-journal">J Neurosci Methods. </span>1994 Jul;<span class="ref-vol">53</span>(1):55–63.</span> [<a href="/pubmed/7990513" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurosci+Methods&amp;title=Quantitative+assessment+of+tactile+allodynia+in+the+rat+paw&amp;author=SR+Chaplan&amp;author=FW+Bach&amp;author=JW+Pogrel&amp;author=JM+Chung&amp;author=TL+Yaksh&amp;volume=53&amp;issue=1&amp;publication_year=1994&amp;pages=55-63&amp;pmid=7990513&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">Arezzo JC, Seto S, Schaumburg HH. Sensory-motor assessment in clinical research trials. <span><span class="ref-journal">Handb Clin Neurol. </span>2013;<span class="ref-vol">115</span>:265–78.</span> [<a href="/pubmed/23931786" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Handb+Clin+Neurol&amp;title=Sensory-motor+assessment+in+clinical+research+trials&amp;author=JC+Arezzo&amp;author=S+Seto&amp;author=HH+Schaumburg&amp;volume=115&amp;publication_year=2013&amp;pages=265-78&amp;pmid=23931786&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Lenk GM, Meisler MH. Mouse models of PI(3,5)P2 deficiency with impaired lysosome function. <span><span class="ref-journal">Methods Enzymol. </span>2014;<span class="ref-vol">534</span>:245–60.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4059992/">PMC free article</a>]</span> [<a href="/pubmed/24359958" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Enzymol&amp;title=Mouse+models+of+PI(3,5)P2+deficiency+with+impaired+lysosome+function&amp;author=GM+Lenk&amp;author=MH+Meisler&amp;volume=534&amp;publication_year=2014&amp;pages=245-60&amp;pmid=24359958&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">Lenk GM, Ferguson CJ, Chow CY, Jin N, Jones JM, Grant AE, et al.  Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J. <span><span class="ref-journal">PLoS Genet. </span>2011 Jun;<span class="ref-vol">7</span>(6):e1002104.</span> doi:10.1371. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3107197/">PMC free article</a>]</span> [<a href="/pubmed/21655088" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Pathogenic+mechanism+of+the+FIG4+mutation+responsible+for+Charcot-Marie-Tooth+disease+CMT4J&amp;author=GM+Lenk&amp;author=CJ+Ferguson&amp;author=CY+Chow&amp;author=N+Jin&amp;author=JM+Jones&amp;volume=7&amp;issue=6&amp;publication_year=2011&amp;pages=e1002104&amp;pmid=21655088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R42">42. <span class="element-citation">Delague V, Jacquier A, Hamadouche T, Poitelon Y, Baudot C, Boccaccio I, et al.  Mutations in FGD4 encoding the Rho GDP/GTP exchange factor FRABIN cause autosomal recessive Charcot-Marie-Tooth type 4H. <span><span class="ref-journal">Am J Hum Genet. </span>2007 Jul;<span class="ref-vol">81</span>(1):1–16.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950914/">PMC free article</a>]</span> [<a href="/pubmed/17564959" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=Mutations+in+FGD4+encoding+the+Rho+GDP/GTP+exchange+factor+FRABIN+cause+autosomal+recessive+Charcot-Marie-Tooth+type+4H&amp;author=V+Delague&amp;author=A+Jacquier&amp;author=T+Hamadouche&amp;author=Y+Poitelon&amp;author=C+Baudot&amp;volume=81&amp;issue=1&amp;publication_year=2007&amp;pages=1-16&amp;pmid=17564959&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R43">43. <span class="element-citation">Nakamichi Y, Udagawa N, Takahashi N. IL-34 and CSF-1: similarities and differences. <span><span class="ref-journal">J Bone Miner Metab. </span>2013 Sep;<span class="ref-vol">31</span>(5):486–95.</span> [<a href="/pubmed/23740288" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Bone+Miner+Metab&amp;title=IL-34+and+CSF-1:+similarities+and+differences&amp;author=Y+Nakamichi&amp;author=N+Udagawa&amp;author=N+Takahashi&amp;volume=31&amp;issue=5&amp;publication_year=2013&amp;pages=486-95&amp;pmid=23740288&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R44">44. <span class="element-citation">Klein D, Patzko A, Schreiber D, van Hauwermeiren A, Baier M, Groh J, et al.  Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. <span><span class="ref-journal">Brain. </span>2015 Nov;<span class="ref-vol">138</span>(Pt 11):3193–205.</span> [<a href="/pubmed/26297559" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Targeting+the+colony+stimulating+factor+1+receptor+alleviates+two+forms+of+Charcot-Marie-Tooth+disease+in+mice&amp;author=D+Klein&amp;author=A+Patzko&amp;author=D+Schreiber&amp;author=A+van+Hauwermeiren&amp;author=M+Baier&amp;volume=138&amp;issue=Pt+11&amp;publication_year=2015&amp;pages=3193-205&amp;pmid=26297559&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R45">45. <span class="element-citation">van der Mark VA, Elferink RP, Paulusma CC. P4 ATPases: Flippases in Health and Disease. <span><span class="ref-journal">Int J Mol Sci. </span>2013 Apr 11;<span class="ref-vol">14</span>(4):7897–922.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3645723/">PMC free article</a>]</span> [<a href="/pubmed/23579954" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Mol+Sci&amp;title=P4+ATPases:+Flippases+in+Health+and+Disease&amp;author=VA+van+der+Mark&amp;author=RP+Elferink&amp;author=CC+Paulusma&amp;volume=14&amp;issue=4&amp;publication_year=2013&amp;pages=7897-922&amp;pmid=23579954&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R46">46. <span class="element-citation">Xu Q, Yang GY, Liu N, Xu P, Chen YL, Zhou Z, et al.  P4-ATPase ATP8A2 acts in synergy with CDC50A to enhance neurite outgrowth. <span><span class="ref-journal">FEBS Lett. </span>2012 Jun 21;<span class="ref-vol">586</span>(13):1803–12.</span> [<a href="/pubmed/22641037" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=P4-ATPase+ATP8A2+acts+in+synergy+with+CDC50A+to+enhance+neurite+outgrowth&amp;author=Q+Xu&amp;author=GY+Yang&amp;author=N+Liu&amp;author=P+Xu&amp;author=YL+Chen&amp;volume=586&amp;issue=13&amp;publication_year=2012&amp;pages=1803-12&amp;pmid=22641037&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R47">47. <span class="element-citation">Zhu X, Libby RT, de Vries WN, Smith RS, Wright DL, Bronson RT, et al.  Mutations in a P-type ATPase gene cause axonal degeneration. <span><span class="ref-journal">PLoS Genet. </span>2012;<span class="ref-vol">8</span>(8):e1002853.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3415440/">PMC free article</a>]</span> [<a href="/pubmed/22912588" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Mutations+in+a+P-type+ATPase+gene+cause+axonal+degeneration&amp;author=X+Zhu&amp;author=RT+Libby&amp;author=WN+de+Vries&amp;author=RS+Smith&amp;author=DL+Wright&amp;volume=8&amp;issue=8&amp;publication_year=2012&amp;pages=e1002853&amp;pmid=22912588&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R48">48. <span class="element-citation">Cacciagli P, Haddad MR, Mignon-Ravix C, El-Waly B, Moncla A, Missirian C, et al.  Disruption of the ATP8A2 gene in a patient with a t(10;13) de novo balanced translocation and a severe neurological phenotype. <span><span class="ref-journal">Eur J Hum Genet. </span>2010 Dec;<span class="ref-vol">18</span>(12):1360–3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3002864/">PMC free article</a>]</span> [<a href="/pubmed/20683487" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Hum+Genet&amp;title=Disruption+of+the+ATP8A2+gene+in+a+patient+with+a+t(10;13)+de+novo+balanced+translocation+and+a+severe+neurological+phenotype&amp;author=P+Cacciagli&amp;author=MR+Haddad&amp;author=C+Mignon-Ravix&amp;author=B+El-Waly&amp;author=A+Moncla&amp;volume=18&amp;issue=12&amp;publication_year=2010&amp;pages=1360-3&amp;pmid=20683487&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R49">49. <span class="element-citation">Onat OE, Gulsuner S, Bilguvar K, Nazli Basak A, Topaloglu H, Tan M, et al.  Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion. <span><span class="ref-journal">Eur J Hum Genet. </span>2013 Mar;<span class="ref-vol">21</span>(3):281–5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3573203/">PMC free article</a>]</span> [<a href="/pubmed/22892528" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Hum+Genet&amp;title=Missense+mutation+in+the+ATPase,+aminophospholipid+transporter+protein+ATP8A2+is+associated+with+cerebellar+atrophy+and+quadrupedal+locomotion&amp;author=OE+Onat&amp;author=S+Gulsuner&amp;author=K+Bilguvar&amp;author=A+Nazli+Basak&amp;author=H+Topaloglu&amp;volume=21&amp;issue=3&amp;publication_year=2013&amp;pages=281-5&amp;pmid=22892528&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R50">50. <span class="element-citation">Prokop A. The intricate relationship between microtubules and their associated motor proteins during axon growth and maintenance. <span><span class="ref-journal">Neural Dev. </span>2013 Sep 8;<span class="ref-vol">8</span>:17.</span> 8104-8-17. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3846809/">PMC free article</a>]</span> [<a href="/pubmed/24010872" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neural+Dev&amp;title=The+intricate+relationship+between+microtubules+and+their+associated+motor+proteins+during+axon+growth+and+maintenance&amp;author=A+Prokop&amp;volume=8&amp;publication_year=2013&amp;pages=17&amp;pmid=24010872&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R51">51. <span class="element-citation">Chhibber A, Mefford J, Stahl EA, Pendergrass SA, Baldwin RM, Owzar K, et al.  Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance) <span><span class="ref-journal">Pharmacogenomics J. </span>2014 Aug;<span class="ref-vol">14</span>(4):336–42.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4111770/">PMC free article</a>]</span> [<a href="/pubmed/24513692" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenomics+J&amp;title=Polygenic+inheritance+of+paclitaxel-induced+sensory+peripheral+neuropathy+driven+by+axon+outgrowth+gene+sets+in+CALGB+40101+(Alliance)&amp;author=A+Chhibber&amp;author=J+Mefford&amp;author=EA+Stahl&amp;author=SA+Pendergrass&amp;author=RM+Baldwin&amp;volume=14&amp;issue=4&amp;publication_year=2014&amp;pages=336-42&amp;pmid=24513692&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R52">52. <span class="element-citation">Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. <span><span class="ref-journal">Pain. </span>2011 Mar;<span class="ref-vol">152</span>(3 Suppl):S2–15.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3268359/">PMC free article</a>]</span> [<a href="/pubmed/20961685" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pain&amp;title=Central+sensitization:+implications+for+the+diagnosis+and+treatment+of+pain&amp;author=CJ+Woolf&amp;volume=152&amp;issue=3+Suppl&amp;publication_year=2011&amp;pages=S2-15&amp;pmid=20961685&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm140129478701008title">Abstract</a></li><li><a href="#S5title">Introduction</a></li><li><a href="#S6title">Methods</a></li><li><a href="#S13title">Results</a></li><li><a href="#S18title">Discussion</a></li><li><a href="#S19title">Supplementary Material</a></li><li><a href="#S20title">Acknowledgments</a></li><li><a href="#idm140129472664256title">Footnotes</a></li><li><a href="#idm140129472661136title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC5050068/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC5050068/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC5050068/pdf/nihms782777.pdf">PDF (294K)</a></li> | <li><a href="#" data-citationid="PMC5050068" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5050068%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5050068%2F&amp;text=Pharmacogenetic%20Discovery%20in%20CALGB%20(Alliance)%2090401%20and%20Mechanistic%20Validation%20of%20a%20VAC14%20Polymorphism%20That%20Increases%20Risk%20of%20Docetaxel-Induced%20Neuropathy" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5050068%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="27143689" data-aiid="5050068" data-aid="5050068" data-iid="276573" data-domainid="319" data-domain="nihpa" data-accid="PMC5050068" data-md5="5e85a1d5a8d52c2922a5c40fdbe8f093">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter shutter_closed ui-ncbitoggler" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-5" role="button" aria-expanded="false" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave" style="display: none;" id="ui-portlet_content-5" aria-hidden="true"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input name="absid" id="absid" value="5050068" type="hidden"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" value="1" type="submit"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-6" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-6" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/25743937" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial.</a><span class="source">[Lancet Oncol. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Petrylak DP, Vogelzang NJ, Budnik N, Wiechno PJ, Sternberg CN, Doner K, Bellmunt J, Burke JM, de Olza MO, Choudhury A, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Lancet Oncol. 2015 Apr; 16(4):417-25. Epub 2015 Mar 3.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/25417775" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance).</a><span class="source">[Cancer. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Patel JN, Jiang C, Hertz DL, Mulkey FA, Owzar K, Halabi S, Ratain MJ, Friedman PN, Small EJ, Carducci MA, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cancer. 2015 Apr 1; 121(7):1025-31. Epub 2014 Nov 21.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/22454414" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.</a><span class="source">[J Clin Oncol. 2012]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kelly WK, Halabi S, Carducci M, George D, Mahoney JF, Stadler WM, Morris M, Kantoff P, Monk JP, Kaplan E, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Clin Oncol. 2012 May 1; 30(13):1534-40. Epub 2012 Mar 26.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/28649702" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Dose considerations for anti-cancer drugs in metastatic prostate cancer.</a><span class="source">[Prostate. 2017]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Crumbaker M, Gurney H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Prostate. 2017 Aug; 77(11):1199-1204. Epub 2017 Jun 26.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/31398933" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation.</a><span class="source">[Genes (Basel). 2019]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-11" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Varnai R, Koskinen LM, Mäntylä LE, Szabo I, FitzGerald LM, Sipeky C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Genes (Basel). 2019 Aug 8; 10(8). Epub 2019 Aug 8.</em>
</div>
</li>
</ul>
<a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=27143689&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=27143689&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-12" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-12" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6754778/" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Concerns regarding use of Patient Reported Outcomes in Biomarker Studies of Chemotherapy-Induced Peripheral Neuropathy</a><span class="source">[The pharmacogenomics journal. ...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hertz DL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">The pharmacogenomics journal. 2019 Aug 9; 19(5): 411-416</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6728179/" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Biological Predictors of Chemotherapy Induced Peripheral Neuropathy (CIPN): MASCC Neurological Complications Working Group Overview</a><span class="source">[Supportive care in cancer : of...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chan A, Hertz DL, Morales M, Adams EJ, Gordon S, Tan CJ, Staff NP, Kamath J, Oh J, Shinde S, Pon D, Dixit N, D’Olimpio J, Dumitrescu C, Gobbo M, Kober K, Mayo S, Pang L, Subbiah I, Beutler AS, Peters KB, Loprinzi C, Lustberg MB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2019 Jul 30; 27(10): 3729-3737</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6723793/" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation</a><span class="source">[Genes. 2019]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Varnai R, Koskinen LM, Mäntylä LE, Szabo I, FitzGerald LM, Sipeky C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Genes. 2019 Aug 8; 10(8): 599</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6519044/" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes</a><span class="source">[Clinical Pharmacology and Ther...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wright GE, Amstutz U, Drögemöller BI, Shih J, Rassekh SR, Hayden MR, Carleton BC, Ross CJ, The Canadian Pharmacogenomics Network for Drug Safety ConsortiumVisscherHenkHAminkengFolefacFHigginsonMichelleMMassahNasimNMiaoFudanFBhavsarAmitALeeJongJBendyshe‐WaltonTessaTTanoshimaReoRJohnsonDavidDZhuwakiCarnationCHoncharikNickNJongGeert‘tGIsraelsSaraSStaubMichelleMRiederMichaelMFaughtLaurenLItoShinyaSNathanPaulPKarandeSmitaSVaillancourtRégisRJohnstonDonnaDNguyenKimmyKBussièresJean‐FrançoisJLebelDenisDJean‐LouisJenniferJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clinical Pharmacology and Therapeutics. 2018 Aug 17; 105(2): 402-410</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6415750/" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment</a><span class="source">[American Society of Clinical O...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-17" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Morton LM, Kerns SL, Dolan ME. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2018 May 23;775-786</em>
</div>
</li>
</ul>
<a class="seemore" href="citedby/" ref="reftype=relart&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-18" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-18" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=5050068" ref="reftype=Compound&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene&amp;IdsFromResult=5050068" ref="reftype=Gene&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Gene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Gene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Gene<div class="brieflinkpopdesc">Gene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=geoprofiles&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_geoprofiles&amp;IdsFromResult=5050068" ref="reftype=GEO%20Profiles&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">GEO Profiles</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-21" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">GEO Profiles<div class="brieflinkpopdesc">Related GEO records</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=5050068" ref="reftype=MedGen&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-22" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pubmed/27143689/" ref="reftype=PubMed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-23" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=snp&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_snp&amp;IdsFromResult=5050068" ref="reftype=SNP&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|SNP&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">SNP</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-24" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">SNP<div class="brieflinkpopdesc">PMC to SNP links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=5050068" ref="reftype=Taxonomy&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Taxonomy</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-25" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-26" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-26" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dd59737dde0893a8bbcb433">Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation o...</a><div class="ralinkpop offscreen_noflow">Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism That Increases Risk of Docetaxel-Induced Neuropathy<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2016 Oct 1; 22(19)4890</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=5dd5970639a66eb03d818a00">Genetic variants in RBFOX3 are associated with sleep latency</a><div class="ralinkpop offscreen_noflow">Genetic variants in RBFOX3 are associated with sleep latency<div class="brieflinkpopdesc">European Journal of Human Genetics. 2016 Oct; 24(10)1488</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=5dd596dd75f66d018fa5c503">Novel Genetic Risk factors for Asthma in African American Children: Precision Me...</a><div class="ralinkpop offscreen_noflow">Novel Genetic Risk factors for Asthma in African American Children: Precision Medicine and The SAGE II Study<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2016 Jul; 68(6-7)391</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=5dd596b339a66eb03d753e57">Identification of Common Genetic Variants Influencing Spontaneous Dizygotic Twin...</a><div class="ralinkpop offscreen_noflow">Identification of Common Genetic Variants Influencing Spontaneous Dizygotic Twinning and Female Fertility<div class="brieflinkpopdesc">American Journal of Human Genetics. 2016 May 5; 98(5)898</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=5dd5968039a66eb03d6e2aa9">Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute ...</a><div class="ralinkpop offscreen_noflow">Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia<div class="brieflinkpopdesc">Journal of Clinical Oncology. 2016 Jun 20; 34(18)2133</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--P5" name="crb--P5" rid="P5" style="position: absolute; visibility: visible; width: 370px; top: 1629px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-27"><ul>
<li class="two_line" reference_id="R1">
<a href="/pubmed/6127342/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Taxol binds to cellular microtubules.</a><span class="one_line_source">[J Cell Biol.  1982]</span><div class="alt-note">
<div class="authors">Manfredi JJ, Parness J, Horwitz SB</div>
<div class="citation">J Cell Biol. 1982 Sep; 94(3):688-96.</div>
</div>
</li>
<li class="two_line" reference_id="R2">
<a href="/pubmed/16575015/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Peripheral neuropathy induced by microtubule-stabilizing agents.</a><span class="one_line_source">[J Clin Oncol.  2006]</span><div class="alt-note">
<div class="authors">Lee JJ, Swain SM</div>
<div class="citation">J Clin Oncol. 2006 Apr 1; 24(10):1633-42.</div>
</div>
</li>
<li class="two_line" reference_id="R3">
<a href="/pubmed/7669713/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Paclitaxel-induced neuropathy.</a><span class="one_line_source">[Ann Oncol.  1995]</span><div class="alt-note">
<div class="authors">Postma TJ, Vermorken JB, Liefting AJ, Pinedo HM, Heimans JJ</div>
<div class="citation">Ann Oncol. 1995 May; 6(5):489-94.</div>
</div>
</li>
<li class="two_line" reference_id="R4">
<a href="/pubmed/23775951/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.</a><span class="one_line_source">[J Clin Oncol.  2013]</span><div class="alt-note">
<div class="authors">Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV</div>
<div class="citation">J Clin Oncol. 2013 Jul 20; 31(21):2699-707.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P6" name="crb--P6" rid="P6" style="position: absolute; visibility: visible; width: 370px; top: 1838px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-28"><ul>
<li class="two_line" reference_id="R5">
<a href="/pubmed/7654432/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Paclitaxel (Taxol) induces cumulative mild neurotoxicity.</a><span class="one_line_source">[Eur J Cancer.  1994]</span><div class="alt-note">
<div class="authors">van Gerven JM, Moll JW, van den Bent MJ, Bontenbal M, van der Burg ME, Verweij J, Vecht CJ</div>
<div class="citation">Eur J Cancer. 1994; 30A(8):1074-7.</div>
</div>
</li>
<li class="two_line" reference_id="R8">
<a href="/pubmed/8102012/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Clinical toxicities encountered with paclitaxel (Taxol).</a><span class="one_line_source">[Semin Oncol.  1993]</span><div class="alt-note">
<div class="authors">Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC</div>
<div class="citation">Semin Oncol. 1993 Aug; 20(4 Suppl 3):1-15.</div>
</div>
</li>
<li class="two_line" reference_id="R9">
<a href="/pubmed/22843789/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.</a><span class="one_line_source">[Clin Cancer Res.  2012]</span><div class="alt-note">
<div class="authors">Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL</div>
<div class="citation">Clin Cancer Res. 2012 Sep 15; 18(18):5099-109.</div>
</div>
</li>
<li class="two_line" reference_id="R12">
<a href="/pubmed/26138065/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.</a><span class="one_line_source">[Clin Cancer Res.  2015]</span><div class="alt-note">
<div class="authors">Schneider BP, Li L, Radovich M, Shen F, Miller KD, Flockhart DA, Jiang G, Vance G, Gardner L, Vatta M, Bai S, Lai D, Koller D, Zhao F, O'Neill A, Smith ML, Railey E, White C, Partridge A, Sparano J, Davidson NE, Foroud T, Sledge GW Jr</div>
<div class="citation">Clin Cancer Res. 2015 Nov 15; 21(22):5082-5091.</div>
</div>
</li>
<li class="two_line" reference_id="R13">
<a href="/pubmed/19223573/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.</a><span class="one_line_source">[Ann Oncol.  2009]</span><div class="alt-note">
<div class="authors">Mir O, Alexandre J, Tran A, Durand JP, Pons G, Treluyer JM, Goldwasser F</div>
<div class="citation">Ann Oncol. 2009 Apr; 20(4):736-40.</div>
</div>
</li>
<li class="two_line" reference_id="R15">
<a href="/pubmed/18628469/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel.</a><span class="one_line_source">[Clin Cancer Res.  2008]</span><div class="alt-note">
<div class="authors">Sissung TM, Baum CE, Deeken J, Price DK, Aragon-Ching J, Steinberg SM, Dahut W, Sparreboom A, Figg WD</div>
<div class="citation">Clin Cancer Res. 2008 Jul 15; 14(14):4543-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P7" name="crb--P7" rid="P7" style="position: absolute; visibility: visible; width: 370px; top: 2091px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-29"><ul>
<li class="two_line" reference_id="R16">
<a href="/pubmed/22454414/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.</a><span class="one_line_source">[J Clin Oncol.  2012]</span><div class="alt-note">
<div class="authors">Kelly WK, Halabi S, Carducci M, George D, Mahoney JF, Stadler WM, Morris M, Kantoff P, Monk JP, Kaplan E, Vogelzang NJ, Small EJ</div>
<div class="citation">J Clin Oncol. 2012 May 1; 30(13):1534-40.</div>
</div>
</li>
<li class="two_line" reference_id="R18">
<a href="/pubmed/373811/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The analysis of failure times in the presence of competing risks.</a><span class="one_line_source">[Biometrics.  1978]</span><div class="alt-note">
<div class="authors">Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE</div>
<div class="citation">Biometrics. 1978 Dec; 34(4):541-54.</div>
</div>
</li>
<li class="two_line" reference_id="R9">
<a href="/pubmed/22843789/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.</a><span class="one_line_source">[Clin Cancer Res.  2012]</span><div class="alt-note">
<div class="authors">Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL</div>
<div class="citation">Clin Cancer Res. 2012 Sep 15; 18(18):5099-109.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P8" name="crb--P8" rid="P8" style="position: absolute; visibility: visible; width: 370px; top: 2404px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-30"><ul><li class="two_line" reference_id="R16">
<a href="/pubmed/22454414/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.</a><span class="one_line_source">[J Clin Oncol.  2012]</span><div class="alt-note">
<div class="authors">Kelly WK, Halabi S, Carducci M, George D, Mahoney JF, Stadler WM, Morris M, Kantoff P, Monk JP, Kaplan E, Vogelzang NJ, Small EJ</div>
<div class="citation">J Clin Oncol. 2012 May 1; 30(13):1534-40.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P10" name="crb--P10" rid="P10" style="position: absolute; visibility: visible; width: 370px; top: 2992px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul><li class="two_line" reference_id="R9">
<a href="/pubmed/22843789/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.</a><span class="one_line_source">[Clin Cancer Res.  2012]</span><div class="alt-note">
<div class="authors">Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL</div>
<div class="citation">Clin Cancer Res. 2012 Sep 15; 18(18):5099-109.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P11" name="crb--P11" rid="P11" style="position: absolute; visibility: visible; width: 370px; top: 3287px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul><li class="two_line" reference_id="R19">
<a href="/pubmed/25689802/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells.</a><span class="one_line_source">[PLoS One.  2015]</span><div class="alt-note">
<div class="authors">Wheeler HE, Wing C, Delaney SM, Komatsu M, Dolan ME</div>
<div class="citation">PLoS One. 2015; 10(2):e0118020.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P12" name="crb--P12" rid="P12" style="position: absolute; visibility: visible; width: 370px; top: 4676px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul><li class="two_line" reference_id="R20">
<a href="/pubmed/17956977/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2007]</span><div class="alt-note">
<div class="authors">Zhang Y, Zolov SN, Chow CY, Slutsky SG, Richardson SC, Piper RC, Yang B, Nau JJ, Westrick RJ, Morrison SJ, Meisler MH, Weisman LS</div>
<div class="citation">Proc Natl Acad Sci U S A. 2007 Oct 30; 104(44):17518-23.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P13" name="crb--P13" rid="P13" style="position: absolute; visibility: visible; width: 370px; top: 4820px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul><li class="two_line" reference_id="R21">
<a href="/pubmed/21521528/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice.</a><span class="one_line_source">[Mol Pain.  2011]</span><div class="alt-note">
<div class="authors">Renn CL, Carozzi VA, Rhee P, Gallop D, Dorsey SG, Cavaletti G</div>
<div class="citation">Mol Pain. 2011 Apr 26; 7():29.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P14" name="crb--P14" rid="P14" style="position: absolute; visibility: visible; width: 370px; top: 5223px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-35"><ul><li class="two_line" reference_id="R18">
<a href="/pubmed/373811/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The analysis of failure times in the presence of competing risks.</a><span class="one_line_source">[Biometrics.  1978]</span><div class="alt-note">
<div class="authors">Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE</div>
<div class="citation">Biometrics. 1978 Dec; 34(4):541-54.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P15" name="crb--P15" rid="P15" style="position: absolute; visibility: visible; width: 370px; top: 5478px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-36"><ul>
<li class="two_line" reference_id="R22">
<a href="/pubmed/22826271/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.</a><span class="one_line_source">[J Clin Oncol.  2012]</span><div class="alt-note">
<div class="authors">Shulman LN, Cirrincione CT, Berry DA, Becker HP, Perez EA, O'Regan R, Martino S, Atkins JN, Mayer E, Schneider CJ, Kimmick G, Norton L, Muss H, Winer EP, Hudis C</div>
<div class="citation">J Clin Oncol. 2012 Nov 20; 30(33):4071-6.</div>
</div>
</li>
<li class="two_line" reference_id="R9">
<a href="/pubmed/22843789/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.</a><span class="one_line_source">[Clin Cancer Res.  2012]</span><div class="alt-note">
<div class="authors">Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL</div>
<div class="citation">Clin Cancer Res. 2012 Sep 15; 18(18):5099-109.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P16" name="crb--P16" rid="P16" style="position: absolute; visibility: visible; width: 370px; top: 5643px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-37"><ul>
<li class="two_line" reference_id="R25">
<a href="/pubmed/17384015/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">GenABEL: an R library for genome-wide association analysis.</a><span class="one_line_source">[Bioinformatics.  2007]</span><div class="alt-note">
<div class="authors">Aulchenko YS, Ripke S, Isaacs A, van Duijn CM</div>
<div class="citation">Bioinformatics. 2007 May 15; 23(10):1294-6.</div>
</div>
</li>
<li class="two_line" reference_id="R26">
<a href="/pubmed/20338662/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">An R function to non-parametric and piecewise analysis of competing risks survival data.</a><span class="one_line_source">[Comput Methods Programs Biomed.  2010]</span><div class="alt-note">
<div class="authors">Filleron T, Laplanche A, Boher JM, Kramar A</div>
<div class="citation">Comput Methods Programs Biomed. 2010 Oct; 100(1):24-38.</div>
</div>
</li>
<li class="two_line" reference_id="R27">
<a href="/pubmed/25285054/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Exact and Asymptotic Weighted Logrank Tests for Interval Censored Data: The interval R package.</a><span class="one_line_source">[J Stat Softw.  2010]</span><div class="alt-note">
<div class="authors">Fay MP, Shaw PA</div>
<div class="citation">J Stat Softw. 2010 Aug; 36(2):.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P22" name="crb--P22" rid="P22" style="position: absolute; visibility: visible; width: 370px; top: 10843px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-38"><ul>
<li class="two_line" reference_id="R9">
<a href="/pubmed/22843789/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.</a><span class="one_line_source">[Clin Cancer Res.  2012]</span><div class="alt-note">
<div class="authors">Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL</div>
<div class="citation">Clin Cancer Res. 2012 Sep 15; 18(18):5099-109.</div>
</div>
</li>
<li class="two_line" reference_id="R10">
<a href="/pubmed/23776197/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.</a><span class="one_line_source">[J Med Genet.  2013]</span><div class="alt-note">
<div class="authors">Leandro-García LJ, Inglada-Pérez L, Pita G, Hjerpe E, Leskelä S, Jara C, Mielgo X, González-Neira A, Robledo M, Avall-Lundqvist E, Gréen H, Rodríguez-Antona C</div>
<div class="citation">J Med Genet. 2013 Sep; 50(9):599-605.</div>
</div>
</li>
<li class="two_line" reference_id="R12">
<a href="/pubmed/26138065/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.</a><span class="one_line_source">[Clin Cancer Res.  2015]</span><div class="alt-note">
<div class="authors">Schneider BP, Li L, Radovich M, Shen F, Miller KD, Flockhart DA, Jiang G, Vance G, Gardner L, Vatta M, Bai S, Lai D, Koller D, Zhao F, O'Neill A, Smith ML, Railey E, White C, Partridge A, Sparano J, Davidson NE, Foroud T, Sledge GW Jr</div>
<div class="citation">Clin Cancer Res. 2015 Nov 15; 21(22):5082-5091.</div>
</div>
</li>
<li class="two_line" reference_id="R13">
<a href="/pubmed/19223573/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.</a><span class="one_line_source">[Ann Oncol.  2009]</span><div class="alt-note">
<div class="authors">Mir O, Alexandre J, Tran A, Durand JP, Pons G, Treluyer JM, Goldwasser F</div>
<div class="citation">Ann Oncol. 2009 Apr; 20(4):736-40.</div>
</div>
</li>
<li class="two_line" reference_id="R15">
<a href="/pubmed/18628469/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel.</a><span class="one_line_source">[Clin Cancer Res.  2008]</span><div class="alt-note">
<div class="authors">Sissung TM, Baum CE, Deeken J, Price DK, Aragon-Ching J, Steinberg SM, Dahut W, Sparreboom A, Figg WD</div>
<div class="citation">Clin Cancer Res. 2008 Jul 15; 14(14):4543-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P25" name="crb--P25" rid="P25" style="position: absolute; visibility: visible; width: 370px; top: 12732px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-39"><ul>
<li class="two_line" reference_id="R20">
<a href="/pubmed/17956977/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2007]</span><div class="alt-note">
<div class="authors">Zhang Y, Zolov SN, Chow CY, Slutsky SG, Richardson SC, Piper RC, Yang B, Nau JJ, Westrick RJ, Morrison SJ, Meisler MH, Weisman LS</div>
<div class="citation">Proc Natl Acad Sci U S A. 2007 Oct 30; 104(44):17518-23.</div>
</div>
</li>
<li class="two_line" reference_id="R28">
<a href="/pubmed/23047693/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2012]</span><div class="alt-note">
<div class="authors">Zolov SN, Bridges D, Zhang Y, Lee WW, Riehle E, Verma R, Lenk GM, Converso-Baran K, Weide T, Albin RL, Saltiel AR, Meisler MH, Russell MW, Weisman LS</div>
<div class="citation">Proc Natl Acad Sci U S A. 2012 Oct 23; 109(43):17472-7.</div>
</div>
</li>
<li class="two_line" reference_id="R29">
<a href="/pubmed/21850385/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel-carboplatin and docetaxel-carboplatin therapy.</a><span class="one_line_source">[Int J Clin Oncol.  2012]</span><div class="alt-note">
<div class="authors">Takemoto S, Ushijima K, Honda K, Wada H, Terada A, Imaishi H, Kamura T</div>
<div class="citation">Int J Clin Oncol. 2012 Aug; 17(4):367-72.</div>
</div>
</li>
<li class="two_line" reference_id="R30">
<a href="/pubmed/23006423/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.</a><span class="one_line_source">[BMC Cancer.  2012]</span><div class="alt-note">
<div class="authors">Niu N, Schaid DJ, Abo RP, Kalari K, Fridley BL, Feng Q, Jenkins G, Batzler A, Brisbin AG, Cunningham JM, Li L, Sun Z, Yang P, Wang L</div>
<div class="citation">BMC Cancer. 2012 Sep 24; 12():422.</div>
</div>
</li>
<li class="two_line" reference_id="R9">
<a href="/pubmed/22843789/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.</a><span class="one_line_source">[Clin Cancer Res.  2012]</span><div class="alt-note">
<div class="authors">Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL</div>
<div class="citation">Clin Cancer Res. 2012 Sep 15; 18(18):5099-109.</div>
</div>
</li>
<li class="two_line" reference_id="R10">
<a href="/pubmed/23776197/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy.</a><span class="one_line_source">[J Med Genet.  2013]</span><div class="alt-note">
<div class="authors">Leandro-García LJ, Inglada-Pérez L, Pita G, Hjerpe E, Leskelä S, Jara C, Mielgo X, González-Neira A, Robledo M, Avall-Lundqvist E, Gréen H, Rodríguez-Antona C</div>
<div class="citation">J Med Genet. 2013 Sep; 50(9):599-605.</div>
</div>
</li>
<li class="two_line" reference_id="R12">
<a href="/pubmed/26138065/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.</a><span class="one_line_source">[Clin Cancer Res.  2015]</span><div class="alt-note">
<div class="authors">Schneider BP, Li L, Radovich M, Shen F, Miller KD, Flockhart DA, Jiang G, Vance G, Gardner L, Vatta M, Bai S, Lai D, Koller D, Zhao F, O'Neill A, Smith ML, Railey E, White C, Partridge A, Sparano J, Davidson NE, Foroud T, Sledge GW Jr</div>
<div class="citation">Clin Cancer Res. 2015 Nov 15; 21(22):5082-5091.</div>
</div>
</li>
<li class="two_line" reference_id="R31">
<a href="/pubmed/24599932/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Replication of genetic polymorphisms reported to be associated with taxane-related sensory neuropathy in patients with early breast cancer treated with Paclitaxel.</a><span class="one_line_source">[Clin Cancer Res.  2014]</span><div class="alt-note">
<div class="authors">Abraham JE, Guo Q, Dorling L, Tyrer J, Ingle S, Hardy R, Vallier AL, Hiller L, Burns R, Jones L, Bowden SJ, Dunn JA, Poole CJ, Caldas C, Pharoah PP, Earl HM</div>
<div class="citation">Clin Cancer Res. 2014 May 1; 20(9):2466-75.</div>
</div>
</li>
<li class="two_line" reference_id="R15">
<a href="/pubmed/18628469/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel.</a><span class="one_line_source">[Clin Cancer Res.  2008]</span><div class="alt-note">
<div class="authors">Sissung TM, Baum CE, Deeken J, Price DK, Aragon-Ching J, Steinberg SM, Dahut W, Sparreboom A, Figg WD</div>
<div class="citation">Clin Cancer Res. 2008 Jul 15; 14(14):4543-9.</div>
</div>
</li>
<li class="two_line" reference_id="R13">
<a href="/pubmed/19223573/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity.</a><span class="one_line_source">[Ann Oncol.  2009]</span><div class="alt-note">
<div class="authors">Mir O, Alexandre J, Tran A, Durand JP, Pons G, Treluyer JM, Goldwasser F</div>
<div class="citation">Ann Oncol. 2009 Apr; 20(4):736-40.</div>
</div>
</li>
<li class="two_line" reference_id="R14" style="display: none;">
<a href="/pubmed/25383449/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Docetaxel-induced neuropathy: a pharmacogenetic case-control study of 150 women with early-stage breast cancer.</a><span class="one_line_source">[Acta Oncol.  2015]</span><div class="alt-note">
<div class="authors">Eckhoff L, Feddersen S, Knoop AS, Ewertz M, Bergmann TK</div>
<div class="citation">Acta Oncol. 2015 Apr; 54(4):530-7.</div>
</div>
</li>
<li class="two_line" reference_id="R32" style="display: none;">
<a href="/pubmed/23413280/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel.</a><span class="one_line_source">[Ann Oncol.  2013]</span><div class="alt-note">
<div class="authors">Hertz DL, Roy S, Motsinger-Reif AA, Drobish A, Clark LS, McLeod HL, Carey LA, Dees EC</div>
<div class="citation">Ann Oncol. 2013 Jun; 24(6):1472-8.</div>
</div>
</li>
</ul><a href="" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P26" name="crb--P26" rid="P26" style="position: absolute; visibility: visible; width: 370px; top: 13161px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-40"><ul>
<li class="two_line" reference_id="R19">
<a href="/pubmed/25689802/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells.</a><span class="one_line_source">[PLoS One.  2015]</span><div class="alt-note">
<div class="authors">Wheeler HE, Wing C, Delaney SM, Komatsu M, Dolan ME</div>
<div class="citation">PLoS One. 2015; 10(2):e0118020.</div>
</div>
</li>
<li class="two_line" reference_id="R33">
<a href="/pubmed/26015512/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy.</a><span class="one_line_source">[Clin Cancer Res.  2015]</span><div class="alt-note">
<div class="authors">Komatsu M, Wheeler HE, Chung S, Low SK, Wing C, Delaney SM, Gorsic LK, Takahashi A, Kubo M, Kroetz DL, Zhang W, Nakamura Y, Dolan ME</div>
<div class="citation">Clin Cancer Res. 2015 Oct 1; 21(19):4337-46.</div>
</div>
</li>
<li class="two_line" reference_id="R11">
<a href="/pubmed/25710658/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.</a><span class="one_line_source">[JAMA.  2015]</span><div class="alt-note">
<div class="authors">Diouf B, Crews KR, Lew G, Pei D, Cheng C, Bao J, Zheng JJ, Yang W, Fan Y, Wheeler HE, Wing C, Delaney SM, Komatsu M, Paugh SW, McCorkle JR, Lu X, Winick NJ, Carroll WL, Loh ML, Hunger SP, Devidas M, Pui CH, Dolan ME, Relling MV, Evans WE</div>
<div class="citation">JAMA. 2015 Feb 24; 313(8):815-23.</div>
</div>
</li>
<li class="two_line" reference_id="R34">
<a href="/pubmed/20417191/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells.</a><span class="one_line_source">[Biochem Pharmacol.  2010]</span><div class="alt-note">
<div class="authors">Rovini A, Carré M, Bordet T, Pruss RM, Braguer D</div>
<div class="citation">Biochem Pharmacol. 2010 Sep 15; 80(6):884-94.</div>
</div>
</li>
<li class="two_line" reference_id="R36">
<a href="/pubmed/19027286/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy.</a><span class="one_line_source">[Eur J Cancer.  2009]</span><div class="alt-note">
<div class="authors">Kawashiri T, Egashira N, Itoh Y, Shimazoe T, Ikegami Y, Yano T, Yoshimura M, Oishi R</div>
<div class="citation">Eur J Cancer. 2009 Jan; 45(1):154-63.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P27" name="crb--P27" rid="P27" style="position: absolute; visibility: visible; width: 370px; top: 13436px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-41"><ul>
<li class="two_line" reference_id="R21">
<a href="/pubmed/21521528/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice.</a><span class="one_line_source">[Mol Pain.  2011]</span><div class="alt-note">
<div class="authors">Renn CL, Carozzi VA, Rhee P, Gallop D, Dorsey SG, Cavaletti G</div>
<div class="citation">Mol Pain. 2011 Apr 26; 7():29.</div>
</div>
</li>
<li class="two_line" reference_id="R37">
<a href="/pubmed/24615440/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Rodent models of chemotherapy-induced peripheral neuropathy.</a><span class="one_line_source">[ILAR J.  2014]</span><div class="alt-note">
<div class="authors">Höke A, Ray M</div>
<div class="citation">ILAR J. 2014; 54(3):273-81.</div>
</div>
</li>
<li class="two_line" reference_id="R38">
<a href="/pubmed/7990513/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Quantitative assessment of tactile allodynia in the rat paw.</a><span class="one_line_source">[J Neurosci Methods.  1994]</span><div class="alt-note">
<div class="authors">Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL</div>
<div class="citation">J Neurosci Methods. 1994 Jul; 53(1):55-63.</div>
</div>
</li>
<li class="two_line" reference_id="R39">
<a href="/pubmed/23931786/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Sensory-motor assessment in clinical research trials.</a><span class="one_line_source">[Handb Clin Neurol.  2013]</span><div class="alt-note">
<div class="authors">Arezzo JC, Seto S, Schaumburg HH</div>
<div class="citation">Handb Clin Neurol. 2013; 115():265-78.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P28" name="crb--P28" rid="P28">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-42"><ul>
<li class="expanded" reference_id="R3">
<a href="/pubmed/7669713/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Paclitaxel-induced neuropathy.</a><span class="one_line_source">[Ann Oncol.  1995]</span><div class="alt-note">
<div class="authors">Postma TJ, Vermorken JB, Liefting AJ, Pinedo HM, Heimans JJ</div>
<div class="citation">Ann Oncol. 1995 May; 6(5):489-94.</div>
</div>
</li>
<li class="expanded" reference_id="R5">
<a href="/pubmed/7654432/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Paclitaxel (Taxol) induces cumulative mild neurotoxicity.</a><span class="one_line_source">[Eur J Cancer.  1994]</span><div class="alt-note">
<div class="authors">van Gerven JM, Moll JW, van den Bent MJ, Bontenbal M, van der Burg ME, Verweij J, Vecht CJ</div>
<div class="citation">Eur J Cancer. 1994; 30A(8):1074-7.</div>
</div>
</li>
<li class="expanded" reference_id="R28">
<a href="/pubmed/23047693/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">In vivo, Pikfyve generates PI(3,5)P2, which serves as both a signaling lipid and the major precursor for PI5P.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2012]</span><div class="alt-note">
<div class="authors">Zolov SN, Bridges D, Zhang Y, Lee WW, Riehle E, Verma R, Lenk GM, Converso-Baran K, Weide T, Albin RL, Saltiel AR, Meisler MH, Russell MW, Weisman LS</div>
<div class="citation">Proc Natl Acad Sci U S A. 2012 Oct 23; 109(43):17472-7.</div>
</div>
</li>
<li class="expanded" reference_id="R20">
<a href="/pubmed/17956977/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-bisphosphate, results in neurodegeneration in mice.</a><span class="one_line_source">[Proc Natl Acad Sci U S A.  2007]</span><div class="alt-note">
<div class="authors">Zhang Y, Zolov SN, Chow CY, Slutsky SG, Richardson SC, Piper RC, Yang B, Nau JJ, Westrick RJ, Morrison SJ, Meisler MH, Weisman LS</div>
<div class="citation">Proc Natl Acad Sci U S A. 2007 Oct 30; 104(44):17518-23.</div>
</div>
</li>
<li class="expanded" reference_id="R40">
<a href="/pubmed/24359958/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Mouse models of PI(3,5)P2 deficiency with impaired lysosome function.</a><span class="one_line_source">[Methods Enzymol.  2014]</span><div class="alt-note">
<div class="authors">Lenk GM, Meisler MH</div>
<div class="citation">Methods Enzymol. 2014; 534():245-60.</div>
</div>
</li>
<li class="expanded" reference_id="R41">
<a href="/pubmed/21655088/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J.</a><span class="one_line_source">[PLoS Genet.  2011]</span><div class="alt-note">
<div class="authors">Lenk GM, Ferguson CJ, Chow CY, Jin N, Jones JM, Grant AE, Zolov SN, Winters JJ, Giger RJ, Dowling JJ, Weisman LS, Meisler MH</div>
<div class="citation">PLoS Genet. 2011 Jun; 7(6):e1002104.</div>
</div>
</li>
<li class="expanded" reference_id="R42">
<a href="/pubmed/17564959/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Mutations in FGD4 encoding the Rho GDP/GTP exchange factor FRABIN cause autosomal recessive Charcot-Marie-Tooth type 4H.</a><span class="one_line_source">[Am J Hum Genet.  2007]</span><div class="alt-note">
<div class="authors">Delague V, Jacquier A, Hamadouche T, Poitelon Y, Baudot C, Boccaccio I, Chouery E, Chaouch M, Kassouri N, Jabbour R, Grid D, Mégarbané A, Haase G, Lévy N</div>
<div class="citation">Am J Hum Genet. 2007 Jul; 81(1):1-16.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P29" name="crb--P29" rid="P29">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-43"><ul>
<li class="expanded" reference_id="R43">
<a href="/pubmed/23740288/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> IL-34 and CSF-1: similarities and differences.</a><span class="one_line_source">[J Bone Miner Metab.  2013]</span><div class="alt-note">
<div class="authors">Nakamichi Y, Udagawa N, Takahashi N</div>
<div class="citation">J Bone Miner Metab. 2013 Sep; 31(5):486-95.</div>
</div>
</li>
<li class="expanded" reference_id="R44">
<a href="/pubmed/26297559/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.</a><span class="one_line_source">[Brain.  2015]</span><div class="alt-note">
<div class="authors">Klein D, Patzkó Á, Schreiber D, van Hauwermeiren A, Baier M, Groh J, West BL, Martini R</div>
<div class="citation">Brain. 2015 Nov; 138(Pt 11):3193-205.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P30" name="crb--P30" rid="P30">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-44"><ul>
<li class="expanded" reference_id="R45">
<a href="/pubmed/23579954/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> P4 ATPases: flippases in health and disease.</a><span class="one_line_source">[Int J Mol Sci.  2013]</span><div class="alt-note">
<div class="authors">van der Mark VA, Elferink RP, Paulusma CC</div>
<div class="citation">Int J Mol Sci. 2013 Apr 11; 14(4):7897-922.</div>
</div>
</li>
<li class="expanded" reference_id="R46">
<a href="/pubmed/22641037/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">P4-ATPase ATP8A2 acts in synergy with CDC50A to enhance neurite outgrowth.</a><span class="one_line_source">[FEBS Lett.  2012]</span><div class="alt-note">
<div class="authors">Xu Q, Yang GY, Liu N, Xu P, Chen YL, Zhou Z, Luo ZG, Ding X</div>
<div class="citation">FEBS Lett. 2012 Jun 21; 586(13):1803-12.</div>
</div>
</li>
<li class="expanded" reference_id="R47">
<a href="/pubmed/22912588/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Mutations in a P-type ATPase gene cause axonal degeneration.</a><span class="one_line_source">[PLoS Genet.  2012]</span><div class="alt-note">
<div class="authors">Zhu X, Libby RT, de Vries WN, Smith RS, Wright DL, Bronson RT, Seburn KL, John SW</div>
<div class="citation">PLoS Genet. 2012; 8(8):e1002853.</div>
</div>
</li>
<li class="expanded" reference_id="R48">
<a href="/pubmed/20683487/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Disruption of the ATP8A2 gene in a patient with a t(10;13) de novo balanced translocation and a severe neurological phenotype.</a><span class="one_line_source">[Eur J Hum Genet.  2010]</span><div class="alt-note">
<div class="authors">Cacciagli P, Haddad MR, Mignon-Ravix C, El-Waly B, Moncla A, Missirian C, Chabrol B, Villard L</div>
<div class="citation">Eur J Hum Genet. 2010 Dec; 18(12):1360-3.</div>
</div>
</li>
<li class="expanded" reference_id="R49">
<a href="/pubmed/22892528/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion.</a><span class="one_line_source">[Eur J Hum Genet.  2013]</span><div class="alt-note">
<div class="authors">Onat OE, Gulsuner S, Bilguvar K, Nazli Basak A, Topaloglu H, Tan M, Tan U, Gunel M, Ozcelik T</div>
<div class="citation">Eur J Hum Genet. 2013 Mar; 21(3):281-5.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P31" name="crb--P31" rid="P31">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-45"><ul>
<li class="expanded" reference_id="R50">
<a href="/pubmed/24010872/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The intricate relationship between microtubules and their associated motor proteins during axon growth and maintenance.</a><span class="one_line_source">[Neural Dev.  2013]</span><div class="alt-note">
<div class="authors">Prokop A</div>
<div class="citation">Neural Dev. 2013 Sep 8; 8():17.</div>
</div>
</li>
<li class="expanded" reference_id="R51">
<a href="/pubmed/24513692/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance).</a><span class="one_line_source">[Pharmacogenomics J.  2014]</span><div class="alt-note">
<div class="authors">Chhibber A, Mefford J, Stahl EA, Pendergrass SA, Baldwin RM, Owzar K, Li M, Winer EP, Hudis CA, Zembutsu H, Kubo M, Nakamura Y, McLeod HL, Ratain MJ, Shulman LN, Ritchie MD, Plenge RM, Witte JS, Kroetz DL</div>
<div class="citation">Pharmacogenomics J. 2014 Aug; 14(4):336-42.</div>
</div>
</li>
<li class="expanded" reference_id="R2">
<a href="/pubmed/16575015/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Peripheral neuropathy induced by microtubule-stabilizing agents.</a><span class="one_line_source">[J Clin Oncol.  2006]</span><div class="alt-note">
<div class="authors">Lee JJ, Swain SM</div>
<div class="citation">J Clin Oncol. 2006 Apr 1; 24(10):1633-42.</div>
</div>
</li>
<li class="expanded" reference_id="R52">
<a href="/pubmed/20961685/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Central sensitization: implications for the diagnosis and treatment of pain.</a><span class="one_line_source">[Pain.  2011]</span><div class="alt-note">
<div class="authors">Woolf CJ</div>
<div class="citation">Pain. 2011 Mar; 152(3 Suppl):S2-15.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--P32" name="crb--P32" rid="P32">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-46"><ul><li class="expanded" reference_id="R9">
<a href="/pubmed/22843789/" ref="reftype=pubmed&amp;article-id=5050068&amp;issue-id=276573&amp;journal-id=319&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.</a><span class="one_line_source">[Clin Cancer Res.  2012]</span><div class="alt-note">
<div class="authors">Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL</div>
<div class="citation">Clin Cancer Res. 2012 Sep 15; 18(18):5099-109.</div>
</div>
</li></ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T14:42:48-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal106&amp;ncbi_phid=CE8D21E5DD58B3710000000007750476&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5050068%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC5050068/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>